Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2022 Mar 1;61(18):e202112372. doi: 10.1002/anie.202112372

Biosensing with Fluorescent Carbon Nanotubes

Julia Ackermann 2,3,+, Justus T Metternich 1,2,+, Svenja Herbertz 2, Sebastian Kruss 1,2,
PMCID: PMC9313876  PMID: 34978752

Abstract

Biosensors are powerful tools for modern basic research and biomedical diagnostics. Their development requires substantial input from the chemical sciences. Sensors or probes with an optical readout, such as fluorescence, offer rapid, minimally invasive sensing of analytes with high spatial and temporal resolution. The near‐infrared (NIR) region is beneficial because of the reduced background and scattering of biological samples (tissue transparency window) in this range. In this context, single‐walled carbon nanotubes (SWCNTs) have emerged as versatile NIR fluorescent building blocks for biosensors. Here, we provide an overview of advances in SWCNT‐based NIR fluorescent molecular sensors. We focus on chemical design strategies for diverse analytes and summarize insights into the photophysics and molecular recognition. Furthermore, different application areas are discussed—from chemical imaging of cellular systems and diagnostics to in vivo applications and perspectives for the future.

Keywords: biosensors, carbon nanotubes, imaging, molecular recognition, near-infrared fluorescence


Optical biosensors are important tools for basic research and non‐invasive diagnostics. Carbon nanotubes are versatile near‐infrared fluorescent and non‐bleaching materials that can be chemically functionalized to detect a broad variety of biomolecules. This Review highlights chemical design strategies and provides a comprehensive overview of the recent developments in this dynamic field.

graphic file with name ANIE-61-0-g027.jpg

1. Introduction

Future challenges in medicine such as early disease detection, point‐of‐care diagnostics, and tailored therapies require novel methods of biosensing. Additionally, biosensors can provide insights into the complex dynamics of biological and chemical systems. Consequently, they are essential tools for both fundamental research and biomedicine. In particular, optical sensing approaches possess a great potential for contactless real‐time readouts that are required in biomedical research, as well as industrial healthcare and agriculture applications.[ 1 , 2 , 3 ] During the last decade, the field of biosensors based on nanomaterials has seen vast improvements.[ 4 , 5 ] These materials include carbon‐based nanomaterials such as graphene, graphene quantum dots, and carbon nanotubes (CNTs).[ 4 , 6 , 7 , 8 ] Here, single‐walled carbon nanotubes (SWCNTs) are of particular interest. Their optoelectronic properties are sensitive to the surrounding environment, which makes them suitable for highly selective biosensing.[ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 ] When dispersed in aqueous solutions, SWCNTs fluoresce without bleaching in the near‐infrared region (NIR, around λ=870–2400  nm).[ 17 , 18 ] This region of the electromagnetic spectrum is beneficial for detection and imaging as it offers an ultralow background and high penetration depths in biological tissues (tissue transparency window).[ 1 , 2 , 9 , 19 , 20 , 21 ] Fluorescence methods using common visible fluorophores often suffer from high scattering, absorption, and autofluorescence, which limits the penetration depth and signal to noise ratios. [1] Additionally, phototoxicity is increased by excitation of common fluorophores with visible (Vis) or ultraviolet (UV) light. Consequently, SWCNTs offer an advantage as they combine the biocompatibility and photostability required for optical sensing and imaging with emission in the NIR region.[ 14 , 22 , 23 ] Furthermore, the structural diversity of SWCNTs promises tunable emission wavelengths.[ 10 , 12 ] SWCNTs are highly sensitive to environmental changes, which is the basis for molecular recognition and was pioneered by optical sensors for glucose detection and DNA polymorphism.[ 24 , 25 ] Both covalent or noncovalent functionalization approaches play an essential role in tailoring molecular interactions close to the SWCNT surface.[ 10 , 14 , 17 , 23 , 26 ] By using such concepts, SWCNT‐based biosensors for many highly important biomolecules have been developed.

More recently, this allowed chemical signaling to be mapped in a completely new manner, for example, release patterns of neurotransmitters from cells with high spatial and temporal resolution, which provides unique insights into fundamental biological questions.[ 27 , 28 ] Moreover, recent advances have been made in remote in vivo biosensing applications by the multimodal optical detection of several analytes. By combining multiple nanosensor elements and integrating them into functional arrays, analytes can be identified and distinguished on the basis of their characteristic image signatures. [29] Such a combination of optical nanosensors could pave the way for the next generation of fast and reliable in situ diagnostics. In addition, these approaches provide completely new opportunities for standoff process controlling, for example, fabrication of antibodies or monitoring in food and agriculture industries (smart plant sensors).[ 3 , 19 , 30 , 31 , 32 , 33 ]

In this Review we focus on optical biosensing with SWCNTs to give an update on this fast‐evolving field. We evaluate in detail the specificity, sensitivity, spatial resolution, and biocompatibility of different SWCNT‐based biosensors. This Review follows on from previous reviews,[ 2 , 10 , 14 , 23 , 34 , 35 ] and discusses new chemical strategies developed in the last few years. SWCNTs can also serve as NIR labels. However, this is not discussed here and we refer to other excellent reviews.[ 1 , 2 ]

In Section 2, the basic structural properties and photophysics of SWCNTs as well as functionalization strategies are described. To conclude this section, we touch on the most important aspects of SWCNT biocompatibility. Section 3 contains an overview of general chemical recognition strategies. We provide a detailed and up‐to‐date summary of all currently accessible biomolecular target groups, including reactive oxygen species (ROS), neurotransmitters, proteins, antibodies, lipids, and sugars. This overview is complemented with mechanistic insights into how these sensors work. Finally, we provide a perspective on the field (Sections 3 and 4) and discuss possible future directions. This includes novel biological topics such as plants, advanced chemical tools (defects), methods for improved (hyperspectral) imaging, novel screening approaches, and multiplexing.

2. Functionalization Concepts

Since the report of their structure, CNTs have attracted wide interest within the scientific community and beyond. Their remarkable mechanical, electrical, and photophysical properties have paved the way for applications in the fields of advanced materials, microelectronics, biosensing, imaging, drug delivery, and many more.[ 8 , 36 ] Here, we will briefly describe the structure and photophysics of SWCNTs, followed by approaches to tailor their surface chemistry and biocompatibility.

2.1. SWCNT Structure and Photophysics

CNTs can be conceptualized as rolled‐up cylinders of graphene. [37] Their properties are determined by the exact sp2‐hybridized carbon lattice as well as by the number of cylinders that are stacked into each other. [37] CNTs derived from a single graphene cylinder are called single‐walled carbon nanotubes (SWCNTs), [38] whereas tubes consisting of multiple layers are called multiwalled carbon nanotubes (MWCNTs). [7] SWCNTs are commonly labeled using the chiral index (n,m), where n and m are integers that describe the carbon lattice structure (Figure 1 a).[ 37 , 39 ] In this notation, the SWCNT is conceptually rolled up along the vector c=na1+ma2 (a1 and a2 are the graphene lattice vectors). Consequently, the roll‐up vector also determines the diameter. For SWCNTs, the reported diameters range from 0.4  nm to 10  nm.[ 8 , 40 ]

Figure 1.

Figure 1

Structure and properties of single‐walled carbon nanotubes (SWCNTs). a) The structure of SWCNTs can be rationalized by rolling a sheet of graphene along its roll‐up vector, for example, c=6a1+5a2. b) The band gap structure gives rise to fluorescence emission in the near‐infrared (NIR) region. c) The E11 transition of SWCNTs [49] overlaps with the tissue transparency window, thus offering the advantage of reduced light absorption, [50] scattering (e.g. Rayleigh), and background fluorescence. Here, the emission spectrum of SWCNTs of (6,5)‐chirality is shown, but the emission wavelength for other chiralities span the whole NIR region.

The roll‐up vector affects the density and energy of the electronic states of SWCNTs and consequently the optoelectronic properties are directly related to chirality. As a result, for nm=0 (armchair configuration), SWCNTs are metallic, for nm=3j (j0 ), semimetallic, and semiconducting for all other (n,m) chiralities. [10] When SWCNTs are excited with light, an electron–hole pair (exciton) can be created and diffuses along the SWCNT axis. [41] For semiconducting SWCNTs, [18] the absorption of photons with energies corresponding to the visible spectrum of light typically leads to excitation to the second conducting band (Figure 1 b).[ 9 , 12 ]

Fast decay (femtosecond time scale) to the first conduction band followed by radiative recombination, then causes fluorescent emission in the NIR region (>870 nm),[ 18 , 42 ] a region that is particularly interesting for biological imaging (Figure 1 c). Quantum chemical considerations predict 4 singlet and 12 triplet excitonic states.[ 43 , 44 ] However, only the transition from the singlet state is optically allowed.[ 43 , 44 ] As the energy of this state is higher than the majority of other singlet and triplet states,[ 43 , 44 ] a variety of dark exciton decay pathways exist. [45] For (6,5)‐SWCNTs, the size of an exciton is approximately 2 nm. [46] During their lifetimes they diffuse in the range of 100 nm along the SWCNT axis.[ 47 , 48 ] As all carbon atoms are located on the surface of the SWCNT, excitons are affected by the nanotube corona (i.e. the organic phase around the SWCNTs). Consequently, the photophysics of SWCNTs are highly influenced by chemical processes around their surfaces. This renders them ideal building blocks and transducers for chemical and biological sensing.

2.2. Surface Functionalization

The extended π‐system makes SWCNTs hydrophobic and consequently they easily aggregate in solvents like water. Therefore, an important step in the preparation of SWCNT‐based sensors is their functionalization to isolate, solubilize and colloidally stabilize single SWCNTs. The functionalization also serves the purpose to a) interact (specifically) with other molecules and b) translate this interaction into a fluorescence change.

In the past years, different covalent and noncovalent modification strategies (Figure 2) have been developed. For a complete overview, we refer the reader to several excellent reviews and discuss only concepts relevant for sensing here.[ 26 , 51 , 52 , 53 ]

Figure 2.

Figure 2

Covalent and noncovalent (bio)functionalization of SWCNTs. Note that only covalent approaches that preserve the NIR fluorescence are included and that double bonds in the SWCNT carbon lattice are not shown for clarity.

On a more abstract level, two strategies to assemble selective SWCNT‐based sensors have been used, namely screening and rational design (Figures 3 and 5). The first one relies on permutations of the organic corona around the SWCNT (e.g. deoxyribonucleic acid (DNA) sequence) whereas the second one uses known recognition motifs (e.g. antibodies).

Figure 3.

Figure 3

Chemical concepts for the design of SWCNT‐based NIR fluorescent sensors. a) Screening of different organic phases identifies biopolymer/SWCNT conjugates with the desired analyte response. b) Rational concepts use known recognition motifs and assemble them on the SWCNT surface. Note that for both concepts colloidal stability in aqueous solution determines the usable reactions.

Figure 5.

Figure 5

Screening approaches based on corona phase molecular recognition (CoPhMoRe). a) The screening of SWCNT–polymer conjugates (x axis, N1–N13: nucleic acids; PL1–PL12: phospholipids; P1–P5: amphiphilic polymers) identifies SWCNT‐based sensor candidates with a strong fluorescence in response to different neurotransmitters (y axis). Reprinted from Ref. [15] with permission. Copyright 2014 American Chemical Society. b) CoPhMoRe screening procedure of SWCNT–polymer conjugates (x axis) for the detection of proteins (y axis). Reprinted from Ref. [71] with permission.

2.2.1. Noncovalent Functionalization

Noncovalent functionalization in aqueous solution is achieved by sonication with surfactants that form micellar structures around the SWCNT or through strong π‐π interactions with the SWCNT surface (Figure 2). Prominent examples of surfactants are sodium dodecylsulfonate (SDS), sodium dodecylbenzenesulfonate (SDBS), sodium cholate (SC), sodium deoxycholate (DOC), lithium dodecyl sulfate, Triton X‐100, and pluronic F127.[ 17 , 26 ] Additionally, functional surfactants—for example, with a perylene core together with a hydrophilic dendron—adsorb through π‐π stacking and enable energy transfer. [54] In general, a surfactant concentration above the critical micelle concentration is required to stabilize dispersed SWCNTs in solution. [17] Thus, these approaches are limited with regards to experiments in complex (biological) systems.

In contrast, functionalization with larger biopolymers enables the formation of stable conjugates. Here, DNA and ribonucleic acid (RNA) form strong π‐stacking interactions between the nucleobases and the SWCNT surface, thereby exposing their negatively charged phosphate backbones and solvating the SWCNT–nucleic acid complex (Figure 2).[ 22 , 55 ] As the conformation of the SWCNT–nucleic acid complex is affected by changes in the local ion concentration,[ 25 , 56 , 57 ] locked nucleic acids have been used as more rigid synthetic derivatives at higher salt concentrations. [57]

As alternative to nucleic acids, [25] certain polycyclic aromatic compounds carrying hydrophilic moieties have effectively solubilized SWCNTs. Similar to the π‐stacking[ 51 , 58 ] of those compounds, the functionalization of SWCNTs with peptides,[ 59 , 60 ] proteins,[ 60 , 61 ] and other polymers[ 62 , 63 ] has been widely demonstrated (Figure 2). SWCNT‐based biosensors have been rationally designed by the attachment of antibodies (or analogues; Figure 4 a,b,d)[ 64 , 65 ] and peptides (Figure 4 e)[ 66 , 67 ] to polymers or by the adsorption of boronic acids (Figure 4 c) [68] and aptamers (Figure 4 f) on SWCNTs. [27] In cases when sonication would destroy the structural integrity of the (bio‐)polymers, primary suspension of the SWCNTs in a surfactant, followed by subsequent exchange to the polymer by dialysis has been employed.[ 24 , 60 , 69 ] An alternative to this rational design is the screening/search for novel organic phases. This concept was named corona‐phase molecular recognition (CoPhMoRe). [70] Here, a heteropolymer adsorbs onto the carbon nanotube surface and forms a new structure (corona) that serves as a molecular recognition site for interaction with an analyte. The biomolecules used are typically amphiphilic with hydrophobic domains that enable SWCNT adsorption and hydrophilic domains to be responsible for the entropic stabilization of the SWCNT in suspension and formation of a binding site for the analyte. [70] It is important to note that the biomolecules/polymers alone do not necessarily need to interact selectively with the analyte of interest.[ 34 , 70 ] As such, the formation of these recognition sites cannot be predicted and are typically found by screening or high‐throughput approaches. Prominent examples of CoPhMoRe screenings are the identification of SWCNT‐based neurotransmitter sensors [15] as well as the adaptation of the CoPhMoRe concept to proteins [71] (Figure 5).

Figure 4.

Figure 4

Rational molecular recognition concepts in SWCNT‐based biosensors. a) Conjugation of His‐tagged troponin antibodies to SWCNTs wrapped with Ni2+‐chelating chitosan for the detection of the cardiac biomarker troponin. Adapted from Ref. [64] with permission. Copyright 2014 John Wiley and Sons. b) Attachment of a nanobody against the green fluorescent protein (GFP) to DNA‐functionalized SWCNTs to target GFP‐tagged proteins in vivo. Adapted from Ref. [47] with permission. Copyright 2019 John Wiley and Sons. c) Adsorbed aryl boronic acids react with sugars, which modulates the SWCNT fluorescence. Adapted from Ref. [68] with permission. Copyright 2012 American Chemical Society. d) Antibody‐DNA‐SWCNT complex for the detection of the ovarian cancer biomarker human epididymis protein 4 (HE4). Adapted from Ref. [65] with permission. e) Short peptides conjugated to DNA adsorbed on SWCNTs enable the binding of cell adhesion receptors. Adapted from Ref. [66] with permission. Copyright 2018 American Chemical Society. f) Serotonin‐binding aptamers on SWCNTs enable the detection of serotonin release from cells. Adapted from Ref. [27] with permission. Copyright 2019 American Chemical Society.

2.2.2. Covalent Functionalization

The covalent functionalization of SWCNTs introduces new σ‐bonds into the sp2‐hybridized SWCNT structure. In contrast to noncovalent functionalization methods, the conjugates promise higher stability. [10] However, the uncontrolled introduction of covalent sp3 bonds (defects) destroys the electronic and optical properties and diminishes the intrinsic NIR fluorescence. [10] One strategy to overcome this problem preserves the sp2‐hybridized structure of SWCNTs during their covalent functionalization. [72] In contrast, a certain number of sp3 defects give rise to novel properties, such as red‐shifted emission features that are capable of single photon emission.[ 53 , 73 , 74 , 75 ] Therefore, these defects are also called quantum defects or quantum color centers. [53]

These sp3 defects have, at low densities, been shown to increase the fluorescence of SWCNTs.[ 53 , 74 , 76 ] Incorporation of these defects at low concentrations leads to the trapping of excitons and an alternative decay pathway (E11 *) that results in a new red‐shifted fluorescence feature (Figure 6 a).[ 74 , 76 ] A wide range of sp3 defects has been incorporated into SWCNTs to increase the fluorescent properties by using diazo ether, aryl halide, (bis‐)diazonium, as well as Billup‐Birch and alkyl halide reductions. [53] Additionally, O‐doping approaches using ozone and light, [75] sodium hypochlorite, [77] as well as hydroperoxides of polyunsaturated fatty acids [78] have been reported to increase the red‐shifted emission of SWCNTs at low defect concentrations (Figure 2).

Figure 6.

Figure 6

Covalent functionalization of SWCNTs. a) The controlled introduction of sp3 defects creates an alternative decay pathway that brightens dark excitons without destroying the normal E11 NIR fluorescence. Reprinted from Ref. [74] with permission. Copyright 2013 Nature Publishing Group. b) Introduction of certain aryl defects as generic handles to functionalize SWCNTs with biomolecules. Adapted from Ref. [79] with permission. c) The protonation of covalently attached aminobenzene groups modifies the energy level of the sp3 defect state and changes the photoluminescence. Adapted from Ref. [85] with permission. Copyright 2015 American Chemical Society. d) Quantum defects change the fluorescence response of DNA‐functionalized SWCNTs to the important biomolecule and neurotransmitter dopamine. (GT)10‐functionalized pristine SWCNTs (pSWCNT) increase their fluorescence in response to dopamine. The same SWCNTs with sp3 defects (dSWCNT) decrease their fluorescence, which shows the strong impact of defects on the sensing mechanism. Adapted from Ref. [87] with permission. Copyright 2021 American Chemical Society.

Covalent functionalization approaches also offer opportunities beyond changes in the photophysics. Defects that can be further functionalized enable the conjugation of important biomolecules. Recently, maleimide defects were used to link proteins such as nanobodies and phenylalanine defects to grow peptides directly on the SWCNT surface, similar to a solid‐phase peptide synthesis [79] (Figure 6 b). The covalent conjugation approach with dichlorotriazine allows subsequent nucleophilic aromatic substitution of the chlorides using amine‐containing linkers[ 72 , 80 ] (Figure 2). Another example are defects that are already able to interact with other biomolecules, such as phenyl boronic acids that interact with saccharides, and change the E11 * (S11 *) and E11 (S11) emissions. [81]

It is interesting to note that the resulting bathochromic shifts (E11 *) caused by sp3 defects can be tuned using the electronic properties of the incorporated moieties.[ 74 , 76 ] That said, defects provide a rich chemical playground and interested readers are referred to several excellent reviews.[ 53 , 82 ] With regards to SWCNTs with aryl defects, electron‐withdrawing substituents generally introduce red‐shifts to the E11 * emission that can be correlated to the Hammet constants (σ) of the substituents.[ 74 , 83 ] Furthermore, the E11 * red‐shift shows a 1/d 2 dependence on the diameter (d) of the SWCNT. [74] The protonation of diethylamino‐substituted aryl defects (σHR2N+=+0.82 vs. σR2N=−0.66) [84] is a good example of the effect caused by the inductive effects of substituents. Furthermore, this type of defects allows a precise sensing of the pH value down to 0.2 units through the changes in the E11 * emission (Figure 6 c). [85] Apart from the introduction of defects for sensing, the covalent functionalization of SWCNTs can be used for site assembly using different (bio‐)polymers and linkers. [86]

Defects also change the exciton decay pathways and, therefore, affect the photophysics and sensing mechanism of SWCNT‐based sensors. This approach was recently used to perturb the sensing and elucidate the rate constants that are involved [87] (Figure 6 d).

In this study it was also found that a small number of defects can inverse the sensing response from a strong increase to a strong decrease in fluorescence.

2.3. SWCNT Biocompatibility

Biocompatibility is highly important for materials in direct contact to biological matter. Even though many biocompatibility studies exist, the conclusions are difficult to compare. [88] The main reason is that different materials, surface reactions, and biological systems are compared, which leads to a noncoherent view. Moreover, the SWCNT field has evolved dramatically over the years and well‐defined chirality pure SWCNTs‐based sensors with ultrahigh purity are available today, whereas older studies used less well‐defined materials. [49] In addition, the application itself determines the perspective. [89] As a research tool, SWCNTs should not affect the biological system in such a way that the results are biased. For long‐term in vivo studies and applications in humans, the fate of SWCNTs in biological systems is highly relevant for their biocompatibility. SWCNTs have been shown to be susceptible to degradation by oxidative processes introduced by neutrophils [90] and macrophages. [91] Furthermore, the functionalization changes the surface properties of the nanotubes and, thus, ultimately the way SWCNTs interact with the molecules in a (biological) system. [92]

For example, endocytosis experiments have shown that the DNA sequence length plays an important role in endocytosis and retention time scales of DNA‐functionalized SWCNTs within mammalian cells. [93] Additionally, experiments using a combination of NIR fluorescence spectroscopy and resonance Raman scattering have been used to analyze the fate of DNA‐functionalized SWCNTs through the endosomal process. [94] Based on the experimental findings, the authors propose that DNA‐SWCNTs enter the cell, where they are transported into early endosomes. Maturation of the endosome begins with a decrease in the luminal pH value, which is followed by a series of physicochemical processes that transform the endosome into a lysosome, where the SWCNTs finally aggregate. [94]

As correct functionalization has been shown to alleviate the pathogenicity of SWCNTs, [95] stable functionalization is one possible way to safeguard the future design of SWCNT‐based sensors in environments where long‐term stability is of the highest importance. Adequately functionalized SWCNTs have been shown to possess excellent biocompatible properties. A good example is the recently published long‐term biodistribution and compatibility assessment of DNA‐encapsulated SWCNTs after intravenous administration in mice. [96] After an initial increase in the SWCNT fluorescence in the liver, the SWCNT fluorescence decreased rapidly over the course of 14 days. [96] The same trend is also seen in the long‐term SWCNT biodistribution in different organs. By using hyperspectral microscopy, low levels of SWCNTs were detected in murine hearts, lungs, livers, kidney, and spleen tissues one month after injection. Assessment of these tissues after three and five months showed no SWCNT fluorescence in lung tissue, or in heart and lung tissues. [96] Moreover, no abnormalities were found in chronically exposed tissues after hematoxylin and eosin (H&E) staining at all observed time points and the assessed biomarkers showed negligible changes up to four months, and minor changes after five months. [96]

The aforementioned studies suggest remarkable opportunities for SWCNTs in biomedical applications. As a consequence of the interplay between different materials, surface reactions, and biological systems it becomes evident that biofunctionalized SWCNTs represent a class of different materials. As for all new materials, the biocompatibility should be evaluated for every type of chirality, purity, functionalization, and route of administration. [96] The scientific community is well‐aware of this problem and it has been pointed out that an assessment of these parameters in the context of biocompatibility depends on the context of the experiment, timescale, and the application of the nanomaterial.[ 88 , 97 ] As a consequence, it is fundamentally important to place experimental data in the right context. [88]

An important requirement for a biocompatible design of SWCNT‐based sensors is an in‐depth understanding of the composition of the protein corona in biological media. In this regard, a recent study characterized the enrichment of certain proteins in the SWCNT corona. [98]

In the future, long‐term studies comparing the biocompatibility of different SWCNT subclasses (purity, chirality, surface chemistry) would be desirable to safeguard the development of biocompatible sensors. A foundation for the standardization of protocols could be the MIRIBEL (Minimum Information Reporting in Bio‐Nano Experimental Literature) reporting standard. [99] As the functionalization of the SWCNT plays a critical role in the biocompatibility of SWCNT‐based sensors, the design of stable SWCNT functionalizations needs to be carefully ensured for long‐term applications. In particular, the recent advances in covalent functionalization strategies might, therefore, offer interesting starting points for future development. [79]

3. SWCNT‐Based Sensors

3.1. Development of Chemical Design Strategies

The discovery of band gap fluorescence from SWCNTs and their structure‐dependent NIR emission wavelength marks the starting point for SWCNT‐based sensors.[ 12 , 18 ] Given the high surface to volume ratio of SWCNTs, it was quickly anticipated that SWCNT fluorescence would be sensitive to the chemical environment. [24] The first generation of sensors targeted mainly smaller molecules including protons and reactive oxygen/nitrogen species (ROS/RNS). In these cases, the fluorescence changes were most likely caused by direct quenching. At the same time, it was discovered that different surface reactions with biopolymers lead to molecular interactions that are surprisingly specific even without using a standard approach with antibodies. This idea was conceptualized as corona‐phase molecular recognition (CoPhMoRe). [70] During the last few years, great progress has been made in the chemical design of sensors for both biomedical and environmental applications. In the next sections we will give an overview on different sensing strategies, organized according to the molecular target. Here, sensing of the target molecule has partly environmental as well as biomedical applications. We focus on the advances in the last few years but also report previous studies (see Tables 1–, 9 in the Appendix).

Table 1.

Detailed overview of fluorescent SWCNT‐based sensors of ROS/RNS.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial

resolution

Temporal resolution

Reversibility

Arsenite[33]

In buffer (NaCl, MES, TES), embedded in plant tissue by syringe infiltration, uptake by plants through the roots

Screening approach:

(GT)5‐SWCNTs

FI increase

TO‐PRO‐1‐(GT)5‐SWCNTs (dye)

FI decrease

In buffer (NaCl) LOD 122 nm

In hyperaccumulator plants theoretical LOD 4.7 nm/1.6 nm after 7/14 days

Over other heavy‐metal ions present in soil, e.g. Mn2+, Cd2+, Pb2+, Ni2+, Hg2+

HiPCO

(9,4) at 1128 nm

Dye for additional fluorescence in the visible range: 540 nm

Sub‐mm for a standoff distance of 1 m

Subcellular with TO‐PRO‐1‐(GT)5‐SWCNTs (visible confocal microscopy)

Real time

Intensity increase of sensors in plants 30 min after 10 μm arsenic introduction, after 5 h 11—15% increase

No

Group 2 and 12 metal ions[199]

In solution (NH4OH, NaOH)

SDBS‐SWCNTs

FI decrease

0.5—5 mm tested

Varying quenching efficiency for different ions and SWCNT chiralities

HiPCO

Analysis of each individual chirality at 925—1425 nm

ND

Measurement after 1 h of metal ion addition

ND

Divalent ions[25,109]

In Tris buffer, blood, black ink, tissue, within living mammalian cells

ssDNA‐SWCNTs

ssDNA tested: (GT)15, (GC)15, 5’‐TAG CTA TGG AAT TCC TCG TAG GCA‐3’

Red‐shift

Concentration and chirality dependent red‐shift for different cations

Hg2+ > Cu2+ > Co2+ > Ca2+ > Mg2+[111]

LOD 3.5 mm/8 mm in blood/tissue

Responds to different divalent ions

Chirality mix

(6,5) peak mostly analyzed

ND

Within minutes

Yes, with dialysis to remove ions

H2O2, H+, Fe(CN)6 3− [200]

Embedded in collagen film

Collagen‐SWCNTs

FI changes in discrete quenching steps

Single molecule

Different quenching equilibrium constants: 1.59/1.37 for H2O2/Fe(CN)6 3− at 20 μm, similar constant for H+ at 0.1 m

HiPCO

(6,5), (10,2), (9,2), (8,7)

900—1600 nm

Single molecule

4 pixels, 900 nm × 900 nm**

Real time

1 s**

H2O2‐ and H+‐ induced quenching reversible with MnO2 catalyst for H2O2/NaOH decomposition

H2O2 [125]

H2O2 emitted from A431 human epidermal carcinoma cells

Collagen‐SWCNTs

FI changes in discrete quenching steps

Single molecule

Over H+, NO, NO2 , NO3 , Dulbecco modified Eagle's medium (DMEM), L‐15, 1O2, O2

NO: largest forward rate constant, but binds nearly irreversibly, nitrites and nitrates: small rate constants

HiPCO

Sub‐μm

Real time

Typical observation time 3000 s

Yes

H2O2 [126]

H2O2 generated from live human umbilical vein endothelial cells stimulated by vascular endothelial growth factor (VEGF) and artificial proangiogenic factor Eu(OH)3 nanorods

Collagen‐SWCNTs

FI changes in discrete quenching steps

Single molecule

12.5—400 nm

see Ref. [125]

Chirality mix

Single molecule

300 nm pixel size**

Real time

1 s**

Yes

H2O2 [111]

Incubated in gemcitabine/ irinotecan‐treated Pancreatic ductal adenocarcinoma (PDAC) cells, implanted in tumors of PDAC murine model in response to gemcitabine

(GT)15‐SWCNTs

FI quenching

Alteration of Raman G‐band intensity

μmol L−1 range tested

ND

HiPCO

Raman G‐band intensity at 1590 cm−1

μm

Real time

Measurement after 0–48 h of gemcitabine‐/irinotecan‐treatment

Yes

H2O2 [31]

Embedded in leaves of Arabidopsis plants, in vivo monitoring of stresses (UV‐B light, high intensity light, pathogen‐related peptide)

Rational approach:

Hemin‐binding‐aptamer SWCNTs

Hemin binds Fe3+, which catalyzes a Fenton‐like reaction of H2O2 into hydroxyl radicals that quench fluorescence

10—100 μm

Over Ca2+, sugar (sucrose, glucose), plant hormone levels (methyl salicylate, abscisic acid (ABA), jasmonate (JA)), mechanical wounding

HiPCO

>900 nm

Sub‐mm with standoff detection

Real time

60/120 min for saturation after pathogen‐/environmental‐related stress (UV‐B‐/high intensity light)

Yes

H2O2 [32]

Embedded in leaves of plants, in vivo monitoring of wound‐induced H2O2 waves and other stresses (high intensity light, heat stress, pathogen‐related peptide)

(GT)15‐SWCNTs

FI decrease

μm—mm

Over other plant analytes (JA, auxin, ABA, salicylic acid, glutamates, Ca2+ ions), NO, NO3 , antioxidant

O2, OH caused FI decrease, but not reversible

HiPCO

950 nm—1250 nm

Sub‐mm for a standoff distance of 1 m

Wave speeds due to different stress treatments from 0.44 to 3.10 cm min−1

Real time

Response within 4 min after wound infliction, recovery after 10–20 min

Yes, due to unbinding or consumption by antioxidants and peroxidases

H2O2 [112]

Embedded in wearable microfibrous textiles, in presence of peroxide‐producing macrophages, incorporated in wound bandages

(GT)15‐SWCNTs

Chiralities show different quenching degree in response to H2O2

5 μm–5 mm

See Refs. [20, 32, 110]

HiPCO

(8,7)/(9,4)

Sub‐μm

Real time

within 5—30 min

Yes, within 50 min

NO/H2O2 [20]

Leaves mounted on microfluidic chamber, in vivo in leaves of Arabidopsis plants

(GT)15‐SWCNTs

FI decrease

Tested: NO in vitro/in vivo 500 μm/50 mm, H2O2 in vitro/in vivo 10 mm/100 μm

See Ref. [110]

Monochiral (7,6)

1135 nm/1131 nm for NO/H2O2

Sub‐μm

Real time

in vitro/in vivo: >600 s/50 s for saturation

Yes

NO[124]

In PBS, macrophage cells, mouse model

Rational approach:

3,4‐diaminophenyldextran‐SWCNTs

FI decrease

LOD in solution/cells 70 nm/200 nm

Over other ROS/RNS (e.g. NO2 , NO3 , ONO2 , HNO, OCl, OH*, H2O2)

Chirality mix

950—1350 nm

Sub‐μm in cells

Real time

Bleaching rate k=0.856 s−1 for (10,5)‐SWCNTs

With reducing agent

NO[13]

Immobilized

Screening approach:

(AT)15‐SWCNTs

FI changes in discrete quenching steps

Single molecule

LOD 300 nm

Over other ROS/RNS, dopamine, NADH, l‐ascorbic acid, riboflavin

HiPCO

900—1400 nm

Single molecule

4 pixels, 580 nm × 580 nm**

Real time

Response time for NO: 1.1 s

Yes

NO[127]

Intravenous injection into mice, localization within the liver

Implantation of alginate‐encapsulated SWCNTs within specific tissue

PEG‐(AAAT)7‐SWCNTs

FI decrease

LOD 1 μm

Less quenching with other ROS/RNS

CoMoCAT‐SWCNTs

(6,5) at 990 nm

Sub‐mm

For injection/implantation within s min−1 (93 % quenching after 30 min)

Yes

NO[128]

In cultures of A375 melanoma cells through micropinocytosis, NO production using NO‐releasing anticancer drug JS‐K

VEGF‐mediated NO production in endothelial cells

(AT)15‐SWCNTs

FI decrease

JS‐K concentrations of 16–28 μm tested

VEGF concentrations between 10 ng mL−1 (LOD) and 100 ng mL−1

See Ref. [13]

HiPCO

Sub‐μm

Real time

400 s to reach steady state (after JS‐K addition)

Yes

NO[19]

In extracted chloroplasts and leaves of Arabidopsis plants, in vivo by infiltration through the leaf lamina

(AT)15‐SWCNTs

FI decrease

40%—60% FI decrease

See Ref. [13]

HiPCO

(8,6), (12,1), (11,3), (8,7), (10,5)

1150—1450 nm

Sub‐μm

Real time

Less than 150 s for reaching steady state (after NO exposure)

ND

O2 [131]

In buffer (NaH2PO4/Na2HPO4)

Screening approach:

10 ssDNA sequences tested, e.g. (GT)10‐, (GT)20‐, (ATT)4‐SWCNTs

FI decrease

Depending on ssDNA and SWCNT chirality, 9—40% quenching with 1 atm O2 compared to samples purged with 1 atm Ar

Relatively insensitive to pH

HiPCO

ND

Within seconds

yes

1 O2 [201]

SWCNTs challenged with different tyrosinase substrates for enzyme‐catalyzed reactions

Tyrosinase‐conjugated‐PEG12‐(GT)15‐amine‐SWCNTs

Red‐shift and FI decrease

0.01–1 mm of tyrosinase substrates

Response curves for different tyrosinase inhibitors measurable, IC50 values of suicide inactivation, e.g. 0.5 mm for kojic acid

For tyrosinase inhibitors which induce suicide inactivation of the enzyme

HiPCO

950—1350 nm

Single‐sensor

Within minutes

0.0281 nm min−1 with l‐tyrosine, 0.75 nm min−1 with pyrogallol

ND

Single protons/pH[47]

Embedded in agarose gel

SDBS‐SWCNTs

FI changes in discrete steps

Single molecule

Response to chemical reactions with acid, base, diazonium reactants

HiPCO

individual chiralities, e.g. (8,6) at 1175 nm, (8,3), (11,1)

Single molecule

4 pixels, 670 nm × 670 nm**

Real time

54 ms**

For acid reactions

[a] FI: fluorescence intensity, ND: not determined, **: limited by the Abbe limit, diffusion, and detection speed.

Table 9.

Detailed overview of fluorescent SWCNT based sensors for epitopes and metabolites from pathogens.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial resolution

Temporal resolution

Reversibility

Distinction between F’‐positive and F’‐negative bacterial strains, specific F’‐negative bacteria[170]

In tissue phantom, mice, SWCNTs injected intravenously

Rational approach:

For distinction: M13 bacteriophage‐SWCNTs

F’‐negative bacteria: Anti‐bacterial antibody‐SWCNTs via streptavidin‐biotin reaction

F’‐negative bacteria: Detection of S. aureus intramuscular infections with 3400 % FI enhancement

Over control (injection of PBS)

HiPCO

μm

Imaging of mice 8–48 h after injection

ND

Distinction between pathogens: S. aureus, S. epidermidis, S. pyogenes, E. faecalis, E. coli, P. aeruginosa [29]

SWCNTs in HG array with low porosity for small molecules (e.g. siderophores) and high porosity for large enzymes, bacteria plated on top, in human synovial fluid, tissue phantom

Spatially encoding, distinction with PCA:

Sensors for specific bacterial targets (rational approach):

1) Lipopolysaccharides (LPS) sensor: LPS‐binding peptide linked to NH2‐(GT)10‐SWCNTs, FI increase

2) Siderophore sensor: hemin‐binding aptamer‐ (HeApta)SWCNTs, HeApta binds to hemin, which brings Fe3+ into proximity of the SWCNT and quenches it. Siderophore can reverse this effect by removing iron, which increases FI again

3) Nuclease activity sensor: calf‐thymus‐(CT‐)DNA‐SWCNTs, report to DNase I and S. aureus nuclease activity due to degradation of CT‐DNA via FI modulation

4) Protease sensor: BSA‐SWCNTs, FI decrease in response to protease

Generic lower‐selectivity sensors to increase the discrimination power of the sensor array:

(GT)10‐, C30‐, (GC)15‐, PEG‐PL‐SWCNTs react to changes in pH, oxygen or protein concentration

For spectrally encoding:

LPS‐(6,5)‐SWCNTs, PEG‐PL‐(9,4),(8,6),(9,5)‐SWCNTs and EB‐NS reference

LPS sensor: up to 12.5 μm

Siderophore sensor: up to 10 μm

LOD in >7 mm depth tissue

Distinction of P. aeruginosa, S. aureus, S. epidermidis, E. coli and of 43 different clinical isolates of S. aureus and S. epidermidis with 80% likelihood

E. faecalis and S. pyogenes not distinguishable

Over human synovial fluid

LPS sensor: responds to different LPS structures with different sensitivity, siderophore sensor: not responsive to weaker chelators such as ethylenediaminetetraacetic acid citrate

Spatial encoding:

CoMoCAT, >900 nm

Spectral encoding:

EB‐NS: 920 nm, (6,5): 920 nm, (9,4), (8,6), (9,5) > 1110 nm

mm for a stand‐off distance of ≥25 cm

Limited by diffusion of analytes through HG

Within 24–72 h distinction possible

ND

[a] FI: fluorescence intensity, ND: not determined, HG: hydrogel.

3.2. Biosensing of Target Analytes

The ongoing advances in the development of recognition strategies have led to powerful biosensors based on SWCNTs. Various targets can be detected with high selectivity and sensitivity by combining a recognition unit with the SWCNTs. Recognition strategies (Figure 3) can mainly be categorized into a screening (Figure 5) and a rational approach (Figure 4). The first approach is in principle achieved with a library of synthetic organic phases (coronas) consisting of different amphiphilic polymers wrapped around SWCNTs and screened against a panel of various analytes to find a selective interaction.[ 15 , 70 , 71 , 100 , 101 ] The latter approach is mostly applied for the detection of larger molecules such as proteins[ 65 , 102 , 103 , 104 , 105 , 106 ] or sugars[ 11 , 107 , 108 ] by conjugating a known binding partner of the target analyte to the SWCNT surface. Several approaches are based on the use of SWCNTs wrapped by single‐stranded DNA (ssDNA), whereby different lengths of the (GT) x sequence is probably the most used sequence up to now.

It has shown its versatility in the detection of divalent ions,[ 25 , 109 ] genotoxins, [110] NO, [20] H2O2,[ 20 , 32 , 110 , 111 , 112 ] riboflavin,[ 49 , 113 , 114 ] doxorubicin, [115] β‐carotene, [116] endolysosomal lipids, [117] arsenite, [33] and neurotransmitters, especially dopamine.[ 15 , 49 , 63 , 80 , 87 , 118 , 119 , 120 , 121 ] This section highlights the major advances from the last few years for different categories of biomolecules. A detailed overview of most of the known fluorescent SWCNT‐based sensors, subdivided into the target categories, can be found in Tables 19 in the Appendix.

3.2.1. ROS/RNS

ROS/RNS are important signaling molecules in many organisms, [122] but their detection is challenging because they diffuse fast and have short lifetimes due to their high reactivity with O2 and other molecules.[ 10 , 123 ] Since the finding of the first NO sensor based on SWCNTs [124] the performance of SWCNT‐based ROS sensors has grown from the first selective detection of NO and H2O2 at the single molecule level[ 13 , 125 , 126 ] and first in vivo applications [127] to a new approach to study NO generation and spatiotemporal imaging of intracellular NO signaling. [128] Recently, a mathematical model that calculated the NO concentration based on the change in the SWCNT fluorescence was derived. [129] This was previously not possible due to a nonlinear fluorescence quenching rate in response to NO. [13]

ROS play a mediating role in the cell‐to‐cell communication of plants to activate defence mechanisms, [122] whereby it has become clear that H2O2 is the primary mediator that responds to different stresses in plants. [130] This has led to novel SWCNT sensor approaches to study ROS within plants.[ 19 , 20 , 31 , 32 ] Wu et al. demonstrated remote H2O2 monitoring of plant health with sensitivity in the plant physiological range by using fluorescent SWCNT‐based sensors. [31] Their rational approach was based on a DNA aptamer that specifically binds to the porphyrin hemin (HeAptDNA‐SWCNT). Hemin binds ferric ions, which undergo a Fenton‐like reaction with H2O2 to produce hydroxyl radicals (Figure 7 a) that directly quench the SWCNT fluorescence. For spatiotemporal in vivo monitoring, SWCNTs were embedded in leaves of plants and the plants exposed to different stresses such as UV‐B, high light intensities, and a pathogen‐associated peptide (flg22; Figure 7 b). The decrease in fluorescence reported remotely different aspects of the stress. These differences in fluorescence intensity quenching offer the possibility to interpret stress patterns in plants.

Figure 7.

Figure 7

In vivo monitoring of plant health. a) SWCNTs functionalized with a DNA aptamer for hemin (HeAptDNA‐SWCNT) serve as a sensor for H2O2, which is an important signaling molecule for plant stress. Hemin catalyzes the reaction of H2O2 to hydroxyl radicals, which quench the fluorescence of the SWCNT. Spatial and temporal changes in the NIR fluorescence intensity in leaves embedded with HeAptDNA‐SWCNT sensors are remotely recorded by a NIR camera to assess plant health. b) The sensor's NIR fluorescence decreases reversibly in the presence of the peptide flg22, which mimics a pathogen attack. Reprinted from Ref. [31]. Copyright 2020 American Chemical Society. c) SWCNTs functionalized with (GT)15‐ssDNA (G‐SWNT) respond to H2O2. d) Bright‐field image of a spinach leaf infiltrated with G‐SWNT (left) and nonresponsive A‐SWNT (right) in combination with a false color plot after wounding shows that only the G‐SWNT spot decreases in intensity. e) Ratiometric sensor response after application of different types of stress. Reprinted from Ref. [32] with permission. Copyright 2020 Springer Nature.

Similar to this approach, Lew et al. developed a platform for H2O2 detection in leaves of different plant species. [32] This sensor platform used a ratiometric approach, with (GT)15‐SWCNTs (G‐SWNT) that respond to H2O2 by quenching, possibly as a result of a charge‐transfer phenomenon, and (AT)15‐(6,5)‐SWCNTs (A‐SWNT) as an invariant reference (Figure 7 c). They infiltrated both G‐SWNT and A‐SWNT into spinach leaves and monitored the H2O2 signal with a standoff detection platform in real time (Figure 7 d). In the presence of different stresses, for example, tissue wounding, distinct waveform characteristics were observed (Figure 7 e), whereby the wave speeds in different plant species post‐wounding differed in the range of 0.44 to 3.10 cm min−1.

In the same manner, Lew et al. developed a SWCNT‐based sensor system for the specific detection of arsenite in plants to monitor the uptake of the toxic heavy‐metal pollutant arsenic by using a self‐powered microfluidic system in real time. [33] For this purpose, they infiltrated the sensors and the invariant reference into leaves of spinach, rice plants, and hyperaccumulating fern, which is able to preconcentrate and extract arsenic from soil (Figure 8 a). The intensity of the sensors increased steadily over several days, with the sensor response of the hyperaccumulating plant being significantly higher than those of the rice and spinach plants (Figure 8 b). Based on a kinetic model, the arsenite concentration in the leaf and the limit of detection (LOD) were calculated to be 4.7 nm and 1.6 nm as a function of the root fresh weight and uptake solution volume after 7 and 14 days (Figure 8 c). These examples show that SWCNT‐based H2O2 sensors are able to report plant stress on a microscopic and macroscopic level with potential applications in smart agriculture.

Figure 8.

Figure 8

Macroscopic detection of small molecules. a) Bright‐field image of leaf (arsenic hyperaccumulator plant Pteris cretica) infiltrated with (GT)5‐SWCNT sensors and a C10‐SWCNT reference. b) Fluorescence intensity change in response to 10 μm arsenite uptake through the roots of a hyperaccumulator, spinach, and rice plants. c) Theoretical LOD as a function of root fresh weight and uptake solution volume after 7 days. Reprinted from Ref. [33] with permission. Copyright 2020 John Wiley and Sons. d) Wireless monitoring of oxidative stress. Schematic representation of fabricated core–shell NIR fluorescent microfibers. e) Fluorescence spectra of the microfibrous material in response to different peroxide concentrations. f) Optical fibrous sample integrated into a commercial wound bandage for real‐time wireless sensing. Adapted from Ref. [112] with permission. Copyright 2021 John Wiley and Sons.

Another macroscopic situation in which H2O2 plays an important role is wound healing. Safaee et al. developed a wearable optical microfibrous material with encapsulated SWCNT‐based sensors (Figure 8 d) to monitor the H2O2 concentration in wounds. [112] Their approach was based on the ratiometric signal of (8,7)/(9,4)‐SWCNT chiralities, which differed in their response to H2O2 (Figure 8 e). The fluorescence signal was invariant to the excitation source distance, and exposure time, which enabled detection within commercial wound bandages with a wireless readout (Figure 8 f). These microfibers encapsulated the SWCNTs for at least 21 days without structural changes.

Furthermore, Zheng et al. reported the selective interactions of SWCNTs coated with ten different ssDNA sequences in response to dissolved oxygen. [131] The SWCNT emission intensity was quenched between 9 to 40 % depending on both the ssDNA sequence and SWCNT chirality in response to 1 atm O2 compared to samples purged with 1 atm argon, thus indicating that stronger coating interactions lead to reduced O2 access to the SWCNT surface. Since the quenching reversed completely after the removal of dissolved oxygen, it is probably based on physisorption on the SWCNT. Thus, the screening for fluorescence quenching by dissolved oxygen provides a simple approach to explore the structure‐selective interactions of ssDNA with SWCNTs.

ROS can also be generated by enzymes and SWCNTs. Yaari et al. demonstrated the first SWCNT‐based sensor that reports the degree of enzymatic suicide inactivation. [201] The approach was based on enzyme‐bound SWCNTs, which report fluorescence modulations by quenching and red‐shifting selectively in response to substrate‐mediated suicide inactivation of tyrosinase. Mechanistic insights revealed that the red‐shifted response is most likely a result of the generation of singlet oxygen during the enzymatic reaction, which leads to the binding of ssDNA on the SWCNT surface. [132]

3.2.2. Neurotransmitters

Neurotransmitters are an important class of signaling molecules. To understand neuronal networks and linked neurological diseases, imaging with high selectivity and spatiotemporal resolution is necessary, which existing methods are currently not able to provide. [133] In the last few years several SWCNT‐based sensors based on functionalization with DNA have been explored and it has been shown that sensitivity and selectivity depend on the exact DNA sequence.[ 100 , 118 , 119 ]

The first SWCNT‐based sensors for the detection of neurotransmitters were reported by Kruss et al. [15] By using a screening approach, it was found that certain ssDNA‐SWCNTs change their fluorescence in the presence of catecholamine neurotransmitters such as dopamine. These sensors were reversible and showed sensitivities in the nanomolar range. Similar sensors were used for the high‐resolution imaging of cellular dopamine efflux from stimulated neuroprogenitor cells. [100] Here, the sensors were immobilized on a collagen‐coated glass substrate to increase cell adhesion, and dopamine‐releasing neuroprogenitor (PC12) cells were cultured on top. In response to a stimulation event, the fluorescence intensity of the sensor layer image consisting of up to 20 000 pixels increased (Figure 9 a,b). This allowed both the spatial and temporal dynamics of dopamine release events to be studied with extraordinary high resolution and to identify hotspots (Figure 9 c,d).

Figure 9.

Figure 9

High‐resolution imaging of dopamine using SWCNT‐based sensor arrays. a) Specific ssDNA‐functionalized fluorescent SWCNTs respond selectively to dopamine. Sensors are immobilized on a glass substrate and dopamine‐releasing neuroprogenitor cells are cultivated on top. The SWCNT fluorescence changes in response to stimulation of the cells. b) Fluorescence intensity change of a single sensor in response to dopamine. c) Three‐dimensional release profiles for dopamine along the border of neuroprogenitor (PC12) cells at different time points relative to the stimulation at t 0. The height and color indicate the relative fluorescence change normalized to the maximum fluorescence change. d) Bright‐field image of the cell stimulated on top of the nanosensor array and corresponding hotspots (blue circles) along the cell border. Arrows indicate positions belonging to the hotspots in the response profile. Reprinted from Ref. [100] with permission.

This approach of imaging many nanosensors under cells is also applicable to other neurotransmitters. Dinarvand et al. imaged the release of serotonin from human blood platelets in real time, [27] as most of the serotonin is stored in blood platelets and not in the brain of humans. This serotonin sensor (NIRSer) consisted of a serotonin‐binding aptamer on a SWCNT, which exhibited an increased fluorescence emission of up to 80 % in response to serotonin (Figure 10 a). High‐resolution images of serotonin release patterns from single cells were obtained by placing the sensors below and around serotonin‐releasing cells (Figure 10 b,c). This approach allows serotonin release to be studied with unprecedented resolution and the time delay between stimulation and release to be resolved.

Figure 10.

Figure 10

High‐resolution imaging of serotonin (5HT) release from cells. a) NIRSer sensor: SWCNTs functionalized with a serotonin aptamer respond selectively to serotonin. b) NIRSer increases its fluorescence in response to serotonin. c) Sensors are immobilized on a surface and serotonin‐releasing cells are cultured on top. Here, blood platelets are used, which contain most of the body's serotonin. d) Color‐coded image of serotonin release from a single platelet at three time points (before, during, and after serotonin release). e) Fluorescence response from a region of interest (ROI, green circle in (d)). The activation and delay time of the onset of serotonin release are marked with arrows. Reprinted from Ref. [27] with permission. Copyright 2020 American Chemical Society.

In a similar fashion, artificially added serotonin was detected in acute brain slices by Jeong et al. [134] In this case, a DNA sequence was found by an expanded screening approach from a library of around 6.9×1010 different ssDNA‐SWCNTs. These ssDNA‐SWCNTs exhibited a selective response to serotonin over serotonin analogues, metabolites, and receptor‐targeting drugs.

The high spatiotemporal resolution of SWCNT‐based neurotransmitter sensors is especially useful when it comes to resolving parallel processes on the subcellular to cell‐network length scale. However, placing the sensors below cells can be a drawback, especially with cells that need to differentiate on this layer for several weeks. Elizarova et al. developed a new sensor paint approach (AndromeDA) to use sensors and study the dopaminergic signaling in primary neurons. [135] In this case, the sensors were adsorbed (′painted′) onto the complex cell networks, which included different cell types. This approach allowed the heterogeneity of dopamine release events to be quantified from up to 100 release sites (varicosities), which is highly important to understand the information processing and plasticity of neurons.

An effect that has to be accounted for in these studies is that SWCNT fluorescence is affected by changes in the local cation concentration, which is also a hallmark of neuronal activity.[ 56 , 57 ] To circumvent this problem, Gillen et al. used locked nucleic acids to develop sensors with improved stability to cation‐induced fluctuations of the fluorescence intensity. [136] By systematically introducing locked bases along the (GT)15‐DNA sequence they found that the fluorescence stability in the presence of Ca2+ ions depends on the type of the locked bases. Certain SWCNT chiralities exhibited improved stability against Ca2+ ions and retained their ability to detect dopamine in the presence of Ca2+ ions, thus highlighting the importance of the exact conformation of the nucleic acid sequence. Moreover, the detection of both Ca2+ and dopamine was possible by monitoring multiple chiralities simultaneous.

Interestingly, the fluorescence responses of SWCNTs suspended in sodium cholate to dopamine and serotonin can be altered by modulating the exposed area by the surfactant concentration. However, such surfactants would not be compatible with cellular systems. [137]

A central challenge in biomedicine is the controlled delivery (uptake, transport, and release) of (nano)materials such as sensors and pharmaceuticals. Even whole cells can serve as vehicles to take up such materials. Certain immune cells (neutrophils) have been shown to be suitable for cargo delivery by hijacking a process known as neutrophil extracellular trap formation (NETosis). During NETosis, cells lyse after rupture of the cellular membrane by chromatin swelling. [138] Meyer et al. showed that human immune cells take up ssDNA‐SWCNT‐based sensors and can be triggered to release the cargo after a certain time by using NETosis. [139] Moreover, the sensors maintained their functionality to detect dopamine and H2O2, which offers opportunities for in vivo delivery.

All these discussed neurotransmitter sensors responded by a fluorescence increase. Interestingly, the introduction of a small number of aryl defects into ssDNA‐functionalized SWCNTs completely reversed the sensing response (Figure 6 d). [87] The E11 emission slightly decreased and strongly decreased the red‐shifted E11 * emission. Apart from new insights into the sensing, this approach enables ratiometric detection schemes. For a more detailed overview on the biological relevance of catecholamine neurotransmitters and alternative detection methods (e.g. electrochemical) readers are referred to the literature.[ 28 , 114 ]

3.2.3. Other Small Molecules

Beyond neurotransmitters, recognition strategies for other small molecules have been developed, for example, adenosine 5′‐triphosphate, [140] nitroaromatics,[ 30 , 141 ] riboflavin,[ 49 , 70 , 142 ] l‐thyroxine, [70] oestradiol, [70] doxorubicin,[ 115 , 143 ] and steroids. [144]

Finding a specific molecular recognition element is difficult for many of these biomolecules, such as hormones, due to their chemical similarity. Therefore, Lee et al. used a polymer self‐templating synthetic approach, which is based on the attachment of a chemical appendage similar in molecular weight and structure to the target analyte to create a binding pocket within the corona. This approach reduced the library size for screening and led to implantable SWCNT‐based sensors for the selective detection of the human steroid hormones cortisol and progesterone. [144]

Recently, the first reversible fluorescent SWCNT‐based sensor for volatile organic compounds was also reported, which has potential for the detection of wine spoilage. [145] For this, Shumeiko et al. used peptide‐encapsulated SWCNTs, which were adsorbed onto a polystyrene cuvette to detect low concentrations of acetic acid (down to 0.05 % (v/v)) in air. Using (6,5)‐SWCNTs, which fluoresce below 1000 nm they demonstrated the detection with a low‐cost Si‐based camera (Figure 11 a). The sensor was exposed to different concentrations of acetic acid, which quenched the fluorescence but was reversible when switching to clean air (Figure 11 b). The ability to identify wine spoilage was investigated by using two wine types with and without the addition of acetic acid to simulate an undesirably high acetic acid concentration (Figure 11 c).

Figure 11.

Figure 11

Detection of volatile compounds in the gas phase. a) Air with analyte (acetic acid) flows to the SWCNT‐based sensors, which produces an optical readout. b) Dynamic response of the sensor to rising acetic acid concentrations. c) Dynamic response of the sensor to wine spiked with acetic acid. Reprinted from Ref. [145] with permission. Copyright 2021, Elsevier.

In an extension of this study, this system was expanded to an array of five different peptide‐encapsulated SWCNTs on a nitrocellulose paper. The optical patterns enabled the distinction of volatile molecules such as ethanol, methanol, and 2‐propanol as well as the aromas of red wine, beer, and vodka by linear discriminant analysis and machine learning. [146]

One way to detect or study small molecules is to mimic parts of larger biomolecules, such as enzymes. Dong et al. screened a library of 24 amphiphilic polymers to find a corona phase which demonstrates a binding specificity very similar to the enzyme phosphodiesterase type 5 (PDE5), which catalyzes the hydrolysis of secondary messengers. [147] The SWCNT‐based sensor consisted of a poly(methacrylic acid‐co‐styrene) motif. This synthetic corona mimics the H loop of the native enzyme and is, thus, able to bind to Vardenafil, a PDE5 inhibitor, and its molecular variant as a result of the unique corona phase configuration. It is selective over other off‐target inhibitors, but not completely over the chemically similar inhibitor Sildenafil.

One of the challenges in SWCNT‐based sensing is the heterogeneous material that is used for most sensors. Even though purification has made tremendous progress, getting access to chirality‐pure SWCNTs with a tailored surface chemistry has been a challenge. Nißler et al. showed sensing of small molecules such as riboflavin and ascorbic acid as well as pH value with chirality‐pure SWCNTs by using aqueous two‐phase extraction and a subsequent surface functionalization exchange process. [49] The chirality‐pure sensors were up to ten‐times brighter than mixtures of SWCNT chiralities, and enabled insights into the impact of chirality and handedness of SWNCTs and the sensing mechanism. Additionally, long‐time stability over 14 days was demonstrated as well as ratiometric and multiplexed sensing based on the non‐overlapping fluorescence spectra (Figure 22 b,c).

Figure 22.

Figure 22

Imaging and excitation approaches. a) Customized portable NIR standoff device enables remote detection (25 cm) by fluorescence sensors, for example, of bacteria.[ 29 , 171 , 188 ] Adapted from Ref. [29] with permission. b) Different possible excitation pathways for fluorescent (6,5)‐SWCNTs. Reprinted from Ref. [189] with permission. Copyright 2018 American Chemical Society. c) Comparison of fluorescence brightness of p‐nitroaryl SWCNTs with introduced sp3 defects wrapped with PEG‐PL (solid circles) on excitation of the KSB (845 nm) or E11 (985 nm) with PEG‐PL‐SWCNTs (open diamonds, KSB excitation). Reprinted from Ref. [190] with permission.

On a macroscopic level, monochiral SWCNTs were used by Nißler et al. to detect polyphenols in and around plants. [148] Polyphenols are secondary metabolites and messenger molecules that are released from leaves and roots as a chemical defence against pathogens and herbivores (Figure 12 a). Certain polyethylene glycol phospholipids (PEG‐PL) were identified for the selective detection of different polyphenols over interfering molecules such as sugars or H2O2. The SWCNT‐based sensors responded through quenching and red‐shifting of up to 20 nm, for example, to tannic acid (TaA, Figure 12 b). To image the plant polyphenol release over time, the sensors were embedded in agar, soybean seedlings were plated on top, and polyphenol secretion was triggered with a pathogen‐derived elicitor, which resulted in a decrease in the NIR fluorescence over time (Figure 12 c). These sensors help to understand this plant defence mechanism and could improve the breeding of stress‐resistant plants for precision agriculture.

Figure 12.

Figure 12

Detection and imaging of plant polyphenols. a) Polyphenols from leaves and roots are released in the immediate vicinity in response to pathogens or herbivores as a defence mechanism. b) SWCNTs functionalized with polyethylene glycol phospholipids (PEG‐PL) respond selectively to polyphenols such as tannic acid (TaA) through a red‐shift and decrease in the fluorescence emission. c) Visible and NIR images of a soybean root plated on top of the sensors (embedded in agar). The plant is challenged with a pathogen elicitor and the NIR fluorescence intensity decreases over time in response to the release of polyphenols in the immediate vicinity of the root. Reprinted from Ref. [148] with permission.

3.2.4. Lipids

The investigation of lipid‐linked diseases is challenging because methods for accurate in vivo monitoring of lipid accumulation have been missing. The Heller group was the first to address this issue by developing a SWCNT‐based optical sensor, which non‐invasively detects the lipid flux within the lumen of endolysosomal vesicles in vitro and in vivo.[ 117 , 149 ] In a first approach, they used (GT)6‐functionalized (8,6)‐SWCNTs, which fluoresce at 1200 nm and responded through a wavelength shift to biological lipids and water‐soluble lipid analogues. [117]

By incubating the sensors with fibroblasts from a lysosomal storage disorder Niemann‐Pick‐type C patient in vitro, the sensors localized in the lumen of endolysosomal organelles without affecting their properties and resolved the lipid accumulation down to the subcellular level in real time. The authors proved the reversibility of this sensor by administering a drug which reverses the disease phenotype.

The second approach was based on the screening of several ssDNA‐SWCNT chirality combinations to identify CTTC3TTC‐(9,4)‐SWCNTs with the greatest wavelength shift of up to 8 nm in response to lipid accumulations. [149] The emission wavelength at 1125 nm is spectrally separated from the lipid absorption band at 1210 nm, thus facilitating promising in vivo applications. Molecular dynamics calculations led to the assumption that the lipid molecules sphingomyelin and cholesterol bind to the SWCNT surface by hydrophobic interactions, thereby decreasing the water density in the SWCNT environment and leading to the observed blue shift (Figure 13 a). To validate the sensor functionality in live cells, endolysosomal lipid accumulation was induced in macrophage cells with chemical inhibitors to mimic different lipid phenotypes. After sensor incubation, a blue‐shift was observed for all sensors within the drug‐treated cells compared to the control (Figure 13 b). For in vivo applications, two mouse models were used with lipid accumulation within the organelles of many cell types, for example, in Kupffer cells. By intravenously injecting the SWCNT‐based sensors, a rapid decrease of the SWCNT fluorescence and consequently removal of SWCNTs from all parts of the mice except for the liver were observed. The sensors were also able to report uptake and endolysosomal lipid accumulation of oxidized low‐density lipoprotein (oxLDL; Figure 13 c). Therefore, these types of sensors provide novel insights into the complexity of lipid metabolism and related health states.

Figure 13.

Figure 13

In vivo detection of lipid accumulation. a) Molecular dynamics simulations of ssCTTC3TTC‐(9,4)‐SWCNTs that serve as a sensor for the lipids cholesterol and sphingomyelin through a change in the SWCNT emission wavelength. b) Bright‐field images overlaid with hyperspectral NIR images of the sensors in RAW 264.7 macrophages with or without the chemical inhibitors U18666A, Lalistat 3a2, and Imipramine that change the intracellular lipid levels. c) Hyperspectral NIR images of the sensor before and after injection of oxLDL in mice report the in vivo lipid status. Reprinted from Ref. [149] with permission.

3.2.5. Proteins

Proteins are one of the major biomacromolecules. Consequently, the study of protein–protein interactions helps to understand the function of proteins or to find novel drugs. [150] As discussed above, the detection of proteins with SWCNTs is either based on attaching a known natural recognition element[ 21 , 64 , 65 , 102 , 103 , 104 , 105 , 106 , 151 ] or a synthetic heteropolymer to the SWCNT surface (Figure 3).[ 71 , 101 , 152 , 153 ] Such studies go beyond detecting the presence of a whole protein.

Williams et al. developed the first label‐free optical sensor for the detection of glutathione‐S‐transferase (GST) fusion proteins based on glutathione‐(TAT)6‐SWCNTs (GSH‐DNA‐SWCNTs; Figure 14 a). [154] The system used distinct differences in the emission wavelength and intensity of SWCNT chiralities in response to GST and, consequently, the ratiometric intensity of two chiralities (8,6)/(9,1) (Figure 14 b). The functionality of this sensor in response to four different GST fusion proteins was tested, which all showed a similar ratiometric response and a LOD in the low nanomolar regime. This approach has potential for the tracking of protein expressions in real time.

Figure 14.

Figure 14

Detection of proteins. a) SWCNT‐based sensor design for the detection of glutathione‐S‐transferase (GST) fusion proteins. b) Monotonic intensity changes of (8,6) and (9,1) sensors with increasing GST concentration. Reprinted from Ref. [154] with permission. Copyright 2020 American Chemical Society. c) Detection of insulin by SWCNTs functionalized with a PEG‐conjugated lipid. Intensity change of the sensor in response to insulin and shorter insulin fragments. d) Insulin calibration curve in serum. Reprinted from Ref. [101] with permission. Copyright 2018 American Chemical Society. e) Detection of the SARS‐CoV‐2 spike protein. ACE2‐(GT)6‐SWCNTs interact with the SARS‐CoV‐2 spike protein receptor‐binding domain (S RBD). f) Time‐dependent change in the relative fluorescence intensity of the sensor in response to the viral protein S RBD. Reprinted from Ref. [157] with permission. Copyright 2021 American Chemical Society.

The detection of insulin is essential for diabetes as it controls the glucose levels in blood. The first optical SWCNT‐based sensor approach for detecting insulin was realized in 2010 by Cha et al. [155] They used an insulin‐binding aptamer, which showed a highly specific and sensitive decrease in the fluorescence intensity on forming a guanine quadruplex. Furthermore, they incorporated these sensors in a collagen extracellular matrix and demonstrated sensor reversibility with enzymatic proteolysis and the detection of insulin secreted by pancreatic β‐cells. [156]

Recently, insulin detection was enabled by screening a library of PEG‐conjugated lipids. It was found that the C16‐PEG(2000 Da)‐Ceramide‐SWCNT complex causes a significant decrease in the fluorescence intensity in the presence of insulin compared to other relevant proteins present in human whole blood. [101] Additionally, nonspecific recognition mechanisms such as hydrophobicity or molecular weight were ruled out. For example, the sensor response to shorter insulin fragments was measured, however no correlation to the molecular weight was observed (Figure 14 c). The analysis of insulin fragments was further supported by enthalpy measurements that showed no affinity of the PEG‐conjugated lipid itself, which highlights that the exact CoPhMoRe phase bound to the SWCNT is responsible for the insulin binding. In more complex environments, such as serum, the sensor affinity was lower but still sensitive enough (Figure 14 d).

The application of sensors in complex biological samples is often challenging. The spontaneous adsorption of proteins onto all kind of materials changes the actual corona structure and might affect sensing. To improve the performance of sensors in those protein‐rich environments, a fundamental understanding of the interaction between sensors and their biological environment is necessary. Pinals et al. addressed this issue by studying the protein corona formation on (GT)15‐SWCNTs in cerebrospinal fluid and blood plasma by mass spectroscopy. [98]

Their results showed strong binding to fibrinogen and other proteins involved in blood clotting, lipid transport, and complement activation. The identification of interactions responsible for the formation of protein corona revealed that the outer corona formation can be reduced by optimizing the electrostatic interactions through the sensor design and dynamic flow conditions (e.g. with lateral flow assays or microfluidic systems), while entropic calculations must be considered for the inner corona. This study highlights the urgent need to investigate sensors not only in simple buffers but biologically complex environments. Most recently, Ehrlich et al. developed a complementary approach using an insulin aptamer (found within the natural insulin gene promoter) functionalized to the SWCNT surface through a (AT)15 ssDNA anchor sequence. [158] In contrast to the synthetic PEGylated‐lipid, which has no prior affinity to insulin, this aptamer possesses a known affinity to insulin. However, the observed sensitivity was lower than the previous approach.

Most of the SWCNT‐based sensors that have been discussed so far were measured in solution. The immobilization of SWCNTs on different porous paper matrices, for example, nitrocellulose, has several advantages for a robust assay. [116] Paper‐based immobilization enabled analyte detection within non‐aqueous solvents such as edible oil, which was previously not possible. To further extend this system the authors used wax to pattern hydrophobic regions onto the paper to create a multiplexed one‐dimensional sensor barcode consisting of different ssDNA‐wrapped SWCNTs.

Another important class in biomedical diagnostics are antibodies. The detection of immunoglobulin G (IgG) with SWCNTs was realized by using chitosan‐wrapped SWCNT noncovalently modified with immunoglobulin‐binding proteins.[ 104 , 151 ] Recently, Kozawa et al. designed a flexible fiber optic interface coupled to nanosensors that was capable of detecting the aggregation status of human IgG by reporting the relative fraction of monomers and dimer aggregates with sizes of 5.6 and 9.6 nm. [159] For this purpose, the SWCNT‐based sensors were incorporated into a hydrogel (HG) and attached to the end of a fiber waveguide. Proteins are also part of pathogens and consequently disease markers. Pinals et al. developed a SWCNT‐based sensor which is functionalized with the angiotensin‐converting enzyme 2 (ACE2), a host protein which shows a high binding affinity for the SARS‐CoV‐2 spike protein (Figure 14 e). [157] A twofold NIR fluorescence increase was detected 90 min after the addition of the purified spike protein (Figure 14 f). Passivation with a hydrophilic polymer was used to enable detection of the spike protein in saliva and viral transport medium.

However, antibodies are not always available for all targets. In addition, the development of new recognition units can be expensive and tedious, which is why new approaches are directed to the development of multiplexed sensor arrays[ 146 , 151 ] to overcome the limited selectivity of existing single sensors. Recently, Yaari et al. developed a SWCNT solution‐based sensor platform to detect multiple gynecologic cancer biomarkers in uterine lavage samples. [160] The array consisted of eleven different ssDNA‐SWCNT sensors, and the optical change in the intensity and wavelength was extracted for twelve chiralities present in the sample, which resulted in 132 individual ssDNA‐SWCNT complexes. With machine learning algorithms a classification accuracy (F1 score) of 0.95 was achieved. With retraining, this sensor platform may not be limited to the detection of cancer biomarkers. The large variety of possible SWCNT chiralities in combination with unlimited SWCNT wrappings opens possibilities to meet the rising demand of new recognition strategies.

3.2.6. Sugars

Sugars are important building blocks and metabolites. Glucose, in particular, is a major target, for which continuous monitoring of the glucose level in blood is desired. SWCNT‐based sensing ranges from the use of glucose‐specific enzymes[ 24 , 161 , 162 ] or proteins [108] to the first affinity sensor based on the competitive binding between glucose and its polymer dextran. [11] Although improvements were made, the first approaches suffered from limited reversibility and/or physiological detection range. One sensor that meets the requirements is based on the functionalization of SWCNTs with glucose oxidase (GOX), a glucose‐specific enzyme. [161] The addition of glucose causes an increase in fluorescence emission. The proposed mechanism is based on SWCNT fluorescence being quenched by defect sites on the SWCNT surface, which are hole‐doped through oxygen adsorption. The addition of glucose causes an oxidation of the GOX wrapping, which behaves as an electron donor and passivates the oxygenated sites of the SWCNT, thereby resulting in a fluorescence increase. This effect is reversible by removing the glucose. The sensor showed responses to five other tested saccharides, but with the highest response to glucose.

Another recognition element for saccharides is phenylboronic acids, which have been used to functionalize SWCNTs noncovalently for the detection of sugars. [68] Recently, covalent aryl‐boronic acid defects were also incorporated in SWCNTs. [81] Upon interaction with fructose and glucose, these sensors decreased in fluorescence intensity and the E11 * signal shifted, which can be used for spectrally encoded sensing.

3.2.7. DNA/RNA

One of the most abundant and important types of biomacromolecules are nucleic acids that store and process genetic information. Using a construct of a complementary capture sequence connected to a (GT)15‐sequence serving as an anchor, thus providing colloidal stability, SWCNTs were recently used to detect hybridization events of microRNA and other oligonucleotides directly in serum, urine, and in mice in vivo. [163] Upon the addition of complementary nucleic acids, a specific blue‐shift for different chiralities upon hybridization was observed. Additionally, the sensor response was reversible through toehold‐mediated strand displacement and the sensors possessed a LOD in the picomolar range.

Further development of this sensor led to the first SWCNT‐based sensor for the detection of HIV in serum. [164] Harvey et al. discovered that SDS‐denaturized serum proteins lead to an enhanced optical response of the SWCNTs in response to DNA hybridizations. They hypothesized that the addition of SDS ensured both the liberation of the viral RNA genome and the denaturation of the proteins which competitively bind to the freed surface of the sensor. The interaction leads to a blue‐shift in the SWCNT emission (Figure 15 a). This was first shown for hybridization with complementary target miR‐19 DNA compared to control R23 DNA (Figure 15 b). A dose‐dependent enhancement of the blue‐shift occurred in the region of the critical micelle concentration of SDS; thus, the denaturation of proteins by SDS is considered to involve an unfolding process of the tertiary structure of the protein to complete denaturation. As the SDS concentration was increased, the amount of denatured protein absorbed onto the SWCNT surface after hybridization of the DNA increased and saturated at 2 % SDS. For HIV detection, the recognition strategy was based on a sensor consisting of (GT)15‐T15‐SWCNTs, which hybridize with the polyadenylation elements of HIV RNA (Figure 15 c). In a similar way, a control sensor with the noncomplementary capture sequence, namely (GT)15‐A15‐DNA, was constructed. The wavelength shifts of both the sensor and negative control in the presence of HIV particles treated with 1 % SDS were recorded over time and and the sensor displaying the complementary capture sequence showed a blue‐shift of around 3 nm after 180 min.

Figure 15.

Figure 15

Detection of viral (HIV) RNA. a) Detection of viral RNA using a HIV lentivirus model. The virus is denatured by SDS, which liberates the RNA genome. It hybridizes to the complementary ssDNA on the SWCNT‐based sensor and increases the free surface area, which is then occupied by serum proteins and causes a blue‐shift of the spectrum. b) Wavelength shift in response to the target miR‐19 DNA or control R23 DNA in bovine serum albumin with various SDS concentrations. c) Kinetics of the response of sensors with complementary ((GT)15T15) and negative control ((GT)15A15) ssDNA in the presence of HIV particles, FBS, and 2 % SDS. Reprinted from Ref. [164] with permission. Copyright 2019 American Chemical Society.

A completely different application of DNA chemistry on SWCNTs was established by Cha et al. Based on the consumption of chemical energy delivered by the RNA molecules, they developed a synthetic motor that transports nanoparticles through the mechanical motion of DNA conformation changes along the SWCNTs. [165] Movements of the motor of over 3 μm with a speed of 1 nm min−1 were observed.

3.2.8. Enzymes

So far, the detection of enzymes with SWCNTs has been shown for the characterization of proteases and DNases as well as cellulases and pectinases. The hydrolytic enzyme activity was measured by Kallmyer et al., who used hydrolytic enzyme wrapped SWCNTs that respond to the target enzyme with a fluorescent intensity quenching because of the degradation of the enzyme‐wrapping. [166] Different polymer wrappings consisting of polysaccharides and polypeptides were used to study cellulase, pectinase, and bacterial protease. Most recently, they used this approach to evaluate the enzyme activity in soil using a low‐cost multiplexed and portable fluorimeter able to perform the measurement outside the laboratory only minutes after extraction from the field. [167] As a consequence of the fresh nature of the soil sample, field tests indicated activities an order of magnitude larger than those obtained in benchtop experiments.

Enzymes are also released by microorganisms, which can be used to fingerprint them. Nißler et al. chemically tailored SWCNTs to detect enzymes such as DNases and proteases. [29] For targeting extracellular proteases, SWCNTs were modified with bovine serum albumin (BSA), which serves as an enzymatic substrate, while SWCNTs were functionalized with calf thymus (CT) DNA for reporting DNase I and S. aureus nuclease activity. The sensors showed a fluorescence decrease, most likely as a result of decomposition of the BSA surface coating. These SWCNT‐based sensors were further used for the discrimination of bacteria, which are known to alter their chemical environment through the release of signaling molecules, enzymes, and metabolites (see section below).

In contrast, Shumeiko et al. used peptide‐encapsulated SWCNTs, which also responded through a fluorescence decrease upon enzymatic digestion of the SWCNT wrapping. [168] They utilized a low‐cost paper‐based dipstick system, with which they evaluated the trypsin activity in urine samples as a mimic for acute pancreatitis, where abnormal trypsin concentrations are common.

To study the enzyme myeloperoxidase, which is involved in the regulation of inflammation processes, He et al. used a ratiometric system based on graphene oxide (GO) wrapped SC‐SWCNT sensors and GO‐wrapped carboxymethylcellulose (CMC)‐SWCNTs as a reference. [169] GO and SC‐SWCNTs showed an opposed fluorescence signal in response to enzymatic degradation. Whereas the blue fluorescence intensity of GO was increased due to oxidation and degradation of GO leading to the formation of graphene quantum dots, the NIR emission of SWCNTs decreased due to the generation of defects on the SWCNT surface. In contrast, the CMC‐SWCNT reference was almost stable as a result of the better surface protection of the CMC‐wrapping.

3.2.9. Epitopes and Metabolites from Pathogens

Microbial infections are one of the major causes of mortality worldwide. Currently, the limited number of diagnostic methods in combination with increasing antibiotic resistances demonstrate the rising need for the rapid, contactless, and specific detection of pathogens such as bacteria. The optical properties of SWCNTs promise advantages for pathogen detection. Bardhan et al. developed M13 bacteriophage functionalized SWCNTs (M13‐SWNTs, Figure 16 a ), which are able to distinguish F′‐positive and F′‐negative bacterial strains by modulation of the fluorescence intensity. [170] The M13 bacteriophage has a known binding affinity to F′‐positive E. coli strains. Therefore, they intramuscularly infected the right flank of living mice with E. coli strains, either F′‐negative DH5‐α strains (Figure 16 b , left) or targeted F′‐positive JM109 strains (Figure 16 b, right) and observed a 1.6‐fold intensity increase over the nonspecific DH5‐α strains. Injection of PBS into the right flank served as a control. To extend this SWCNT‐based label to a wider range of bacterial strains lacking F′‐pili, they additionally attached an antibacterial antibody on those M13‐SWCNTs (anti‐S. aureus‐M13‐SWNT) through a streptavidin–biotin reaction. This complex specifically detected S. aureus intramuscular infections in a mouse model in vivo (3.1‐fold intensity increase over the nontargeted M13‐SWCNTs, Figure 16 c).

Figure 16.

Figure 16

Labeling of bacteria. a) The bacteriophage M13 and its proteins p8 and p3 are used to longitudinally functionalize the SWCNT and to bind a target. b) Fluorescence image of M13‐SWCNTs, intravenously injected into mice infected with E. coli strains. The right flank is either infected with F′‐negative E. coli DH5‐α strains (left) or the targeted F′‐positive E. coli JM109 strains (right). The left flank serves as a control (PBS). c) Fluorescence images of mice infected with S. aureus strain Xen‐29. The left mouse received M13‐SWCNTs, while the right mouse received antibody labelled sensors (anti‐S. aureus‐M13‐SWNTs). Adapted from Ref. [170] with permission. Copyright 2014 Nature Publishing Group.

This approach is a NIR labeling rather than sensing. In contrast, Nißler et al. created a concept to remotely distinguish six important pathogens using an array of SWCNT‐based sensors: [29] four for specific bacterial target detection based on a rational approach and four generic lower sensitivity sensors together with an invariant reference consisting of NIR fluorescent Egyptian Blue nanosheets (Figure 17 a). [171]

Figure 17.

Figure 17

Remote detection of pathogens. a) Eight fluorescent SWCNT‐based nanosensors and one NIR fluorescent reference material are incorporated into a polyethylene glycol hydrogel (HG) array that is remotely monitored in the NIR region. The sensors change their fluorescence signal in response to bacterial metabolites and virulence factors, which are released by bacteria growing on top of this HG. b) The unique NIR fingerprint of the multiplexed sensor array allows important pathogens to be differentiated. c) Principal component analysis (PCA) of the fluorescence fingerprint of all the analyzed strains (72 h). Each point represents one bacterial sample, including clinical isolates from different patients. The clusters show that different bacteria can be identified and distinguished. Control=medium only. Reprinted from Ref. [29] with permission.

To overcome unspecific effects arising from the complex composition of bacterial media, the sensors were incorporated into a hydrogel (HG) array, in which the pore size was varied in accordance to the size of the analyte. For the detection of small molecules (such as siderophores), HGs with a low porosity were used, whereas HGs with a high porosity allowed large enzymes to diffuse to the sensors. The sensors were exposed to clinical isolates of bacteria and the unique change in the fluorescence intensity for each sensor was monitored remotely. Within 24–72 h, a unique fingerprint in response to the tested pathogens was visible (Figure 17 b), which further allowed differentiation of the pathogens by principal component analysis (PCA; Figure 17 c). Besides this spatially encoding, spectral multiplexing was implemented to differentiate S. aureus and P. aeruginosa by using two monochiral SWCNT‐based sensors with different wavelengths compared to the reference. Moreover, the signal of the sensor could be detected through tissue to a depth of >7 mm, which highlights the potential for biomedical in vivo applications.

3.3. Mechanism of Fluorescence Modulation

In SWCNT‐based sensors or probes, the SWCNTs serve as transducer elements that translate chemical changes caused by an analyte in the vicinity of the SWCNT into a fluorescent signal. Thus, SWCNT‐based sensing involves molecular recognition and signal transduction. The precise mechanisms are most likely different for different analytes and different surfaces. However, from the literature one can distinguish several possible generic mechanisms (Figure 18).

Figure 18.

Figure 18

Mechanisms of fluorescence modulation in SWCNT‐based biosensors. Note that the size of the objects and their arrangement is simplified and not to scale.

3.3.1. Direct Quenching

Direct quenching, that is, the decrease of fluorescence, is caused by adsorption of the analyte onto the SWCNT surface. Changes in the pH value caused by the addition of an acid can cause protonation of the SWCNT sidewall and result in direct, reversible quenching of the SWCNT fluorescence (Figure 19 a). Mechanistically, this can be explained by the injection of an electron hole into the π‐system near the protonation site. [47] Excitons encountering such an electron hole will be quenched through a nonradiative Auger process. [172] Furthermore, electron transfer between the valence band of 3,4‐diaminophenyldextran‐functionalized SWCNTs and the lowest unoccupied molecular orbital (LUMO) of nitrogen oxide results in rapid, reversible quenching of the SWCNT fluorescence. [124] Both of these interactions take part in the vicinity of the SWCNT and, consequently, solvent effects should play a large role.

Figure 19.

Figure 19

Insights into the mechanism of SWCNT‐based sensors. a) Change in the fluorescence signal of an individual (7,6)‐SWCNT upon successive addition of acid (▾) and base (▴). Luminescence recovery is observed after base addition, which indicates direct quenching by protons. Adapted from Ref. [47] with permission. b) Correlation between the fluorescence response of different SWCNT/polymer conjugates for different analytes (replicate symbols), such as dopamine and ascorbic acid, and the redox potential. The spread along the y axis indicates that the redox potential alone cannot explain the fluorescence change. Adapted from Ref. [63] with permission. Copyright 2016 American Chemical Society. c) There is also no simple correlation between the fluorescence response and surface coverage, shown here for ssDNA‐functionalized SWCNTs and the response to riboflavin. Adapted from Ref. [176] with permission. Copyright 2019 American Chemical Society. d) Mode of interaction between dopamine and DNA‐functionalized SWCNTs. The hydroxy groups of dopamine interact with the phosphate groups of the DNA backbone, which pulls them closer to the SWCNT surface. Most likely, solvation effects play an important role. e) Corresponding potential landscape on a SWCNT functionalized with (GT)15 DNA. The blue regions with changed potential colocalize with the dopamine interactions site and affect the exciton fate. In this particular case, the fluorescence quantum yield increases. Adapted from Ref. [100] with permission. f) Wavelength shift in response to an interaction between ssDNA‐suspended SWCNTs with SDBS, a surfactant. The hybridization of ssDNA is influenced by the salt concentration and changes the surface accessibility of the SWCNT. Reprinted from Ref. [177] with permission. Copyright 2018 American Chemical Society.

3.3.2. Impact of Conformational Changes and Solvation

Within the dimensions of the exciton, the fluorescence of SWCNTs is very sensitive to the surrounding environment. To study the contributions of the solvent to the fluorescence of SWCNTs, fluorescence spectra were analyzed in different dielectric environments.[ 173 , 174 ] By using the solvatochromic shifts, a semiempirical scaling model was developed that linked optical with structural parameters and suggested an inverse dependence of exciton polarizability on the diameter and the square of the transition energy. [173] In nonpolar solvents, the solvatochromic modulation of the fluorescence intensity becomes more pronounced for larger diameters. [174] Changes in the solvatochromic shift, on the other hand, were more pronounced for SWCNTs with smaller diameters. [174]

In general, the displacement of H2O or DNA from the surface of SWCNTs by surfactants leads to a strong blue‐shift and increase in the fluorescence intensity. Interestingly, the change in the fluorescence characteristics of pristine SWCNTs and DNA‐coated SWCNTs immobilized in gel are highly similar. This suggests that considerable portions of the nanotube surface are exposed to H2O. [175] However, to date, a local model of solvatochromism that accounts for the nonhomogeneous structure around SWCNTs is missing.

One of the best understood systems is the recognition of small molecules by DNA‐functionalized SWCNTs. Here, the mechanism of sensors for catecholamine neurotransmitters such as dopamine have been studied in greater detail (Figure 19 d,e).

As these molecules are redox‐active, they could reduce or oxidize either the SWCNT or the surrounding organic phase, thereby affecting the fluorescent properties. To study this potential mechanism, the redox potential and the fluorescent response of certain analytes were correlated. This study showed that molecules with a negative redox potential are more likely to increase the SWCNT fluorescence (Figure 19 b). [63] However, as molecules of the same redox potential can induce drastically different fluorescence responses, the redox potential alone cannot account for the fluorescence changes observed. [63] Likewise, fluorescent responses of ssDNA‐functionalized SWCNTs to dopamine and riboflavin cannot be correlated to the amount of adsorbed nucleotides/DNA molecules on the SWCNT surface (Figure 19 c), which suggests that more complex conformational changes are responsible for the change in the SWCNT fluorescence. [176] Molecular dynamics simulations showed that a stacking of dopamine with DNA‐functionalized SWCNTs leads to interactions between the phosphate backbone of the DNA as well as the hydroxy and amine groups of dopamine (Figure 19 d,e). [100] As a result of this interaction, the phosphate backbone moves toward the SWCNT surface and the electrostatic potential at the SWCNT surface changes (Figure 19 d,e). [100] It is also known that the diffusion coefficient of the excitons in surfactant‐containing systems changes with the surfactant identity and, furthermore, correlates with the fluorescence intensity. [48]

As pristine SWCNTs do not show any fluorescence response to dopamine [100] and differently functionalized SWCNTs display different affinities to neurotransmitters, [118] it follows that the organic phase (DNA) governs both the sensitivity as well as selectivity for this neurotransmitter. [118] The used biopolymers are typically charged and, consequently, electrostatic interactions play an integral part for biosensing. [177] It has been shown that the presence of certain salts alters the conformation of the DNA wrapping on the SWCNT[ 56 , 57 ] and decreases the electrostatic repulsions between equally charged molecules. [177] To reduce ion‐induced fluorescence effects, the flexibility of the DNA can be altered by using xeno nucleic acids. [57] A good example of the influence of electrostatic repulsion and screening effects is the increased SWCNT surface accessibility at higher salt concentrations (Figure 19 f). [177] In a surfactant‐containing system, the exposed surface is covered by the surfactant, which causes a blue‐shift of the NIR fluorescence, again demonstrating that the dynamics of the organic phase around the SWCNT is crucial for the sensing mechanism. [177]

By modulating the exposed surface area, it is furthermore possible to tune surfactant‐suspended SWCNTs to respond to different bio‐analytes. [137] Together, these findings indicate that fluorescence is modulated by the precise 3D arrangement of the molecules, ions, and water molecules in the vicinity of the nanotube.

3.3.3. Exciton Decay and Defects

As described above, the introduction of certain sp3 defects into the carbon lattice of SWCNTs can increase the NIR fluorescence through the trapping of excitons.[ 53 , 74 ] The defined introduction of quantum defects, thus, provides a way to perturb the exciton decay and elucidate the involved processes that ultimately affect the fluorescent response. As the NIR fluorescent response of SWCNT‐based sensors to dopamine in H2O and D2O did not show major differences, electronic‐to‐vibrational energy transfer (EVET) [178] seems not to be a main factor in (dopamine) sensing. [87] In contrast, the correlation between the length of the SWCNTs and their fluorescent response seems to indicate that quenching at the ends plays a role. However, the fluorescence response was independent of the variation of defect density. [87] Together with the finding that a small number of quantum defects reverse the fluorescent response of DNA‐functionalized SWCNTs to dopamine (Figure 6 d), it follows that multiple rate constants are affected by the analyte. [87] Computationally, the experiments were best explained by a three rate constant model (3RC) that includes a decrease in the nonradiative decay from the E11 state (k nr), an increase in the exciton diffusion constant (De), and an increase in the nonradiative decay constant from the E11 * (k nr *) caused by dopamine. [87] Together, these insights highlight the complex interplay between photophysics and molecular recognition as well as new avenues to tailor sensing using defects.

3.4. Considerations on Kinetics and Imaging

The processes related to sensing happen on a certain time scale. How fast an analyte binds or dissociates from a sensor is determined by its kinetics. Additionally, the optical signal is detected in setups that determine aspects such as spatial resolution or imaging speed. In the following sections we discuss how these hallmarks of fluorescence sensors affect their performance.

3.4.1. Kinetics of Sensors and Impact on Spatiotemporal Resolution

Chemical imaging with many SWCNT‐based sensors at one time is a highly effective strategy to gain chemical information from a sample with outstanding spatial and temporal resolution. [179] To understand how the collective image of such an array of sensors reflects the concentration of an analyte, Meyer et al. used stochastic Monte Carlo simulations to study the kinetic requirements for spatiotemporal chemical imaging with nanoscale sensors such as SWCNTs. [180]

The subject of the simulation was a nanosensor array being exposed to a changing concentration gradient of an analyte. To predict the image one gains from many sensors, single sensor responses were first simulated. In a typical scenario, the time‐dependent concentration/diffusion profile of a dynamic process, such as release of signaling molecules (e.g. neurotransmitters) from cells and the stochastic binding site state of the sensors for certain rate constants, was simulated to calculate the expected fluorescence change of single sensors (Figure 20 a,b). The overall image was then calculated considering the individual fluorescence emission point spread functions and technical considerations, such as the frame rate of the camera. This simulation allows the prediction of how the rate constants of a sensor (k on, k off) and other factors affect the spatiotemporal resolution, for example, to resolve fast concentration changes such as neurotransmitter release from cells. It can serve as guiding principle for the chemical design but also for the interpretation of signals from a given biological problem. Phase diagrams (Figure 20 c) indicated that the senors need a surprisingly low affinity (K d=100 μm) to resolve fast processes.

Figure 20.

Figure 20

Kinetic requirements of sensors for spatiotemporal imaging. a) A stochastic‐kinetic simulation allows the binding states (blue) to be predicted and consequently the fluorescence traces of single sensors in response to a changing concentration profile (red), for example, release of molecules from a cell. b) Relative intensity response of a single sensor over time based on the concentration profile shown in (a) and the assumption of 10 binding sites. c) Spatial and temporal resolution phase diagram as a function of rate constants. The red regions show combinations of rate constants that allow the detection of the biological events (here, release of molecules from a cell). Reprinted from Ref. [180] with permission. Copyright 2017 American Chemical Society.

3.4.2. Ratiometric Detection

So far, optical biosensors based on SWCNTs have mainly been fabricated from mixtures of multiple chiralities. This leads to a large spectral overlap in the fluorescence emission, which complicates multiplexing and reduces sensitivity.

Advances in the separation and functionalization of SWCNTs have recently enabled the sole use of SWCNTs emitting below 1000 nm together with low‐cost silicon‐based detectors[ 145 , 181 ] for the development of ratiometric sensors,[ 20 , 29 , 30 , 32 , 33 , 112 , 121 , 154 , 169 ] in which two or more distinct NIR signals are detected simultaneously. Here, one SWCNT chirality is typically not responsive to the analyte and acts as a reference. Besides the fact that single chirality SWCNTs lead to six‐ to tenfold higher fluorescence intensities compared to multichirality SWCNT mixtures at the same concentration,[ 49 , 182 ] ratiometric approaches are more stable to external noise. Despite the clear advantages, the implementation was not possible for a long time because of difficulties in gaining chirality‐pure SWCNTs.

Although progress was made in the synthesis of chirality‐enriched SWCNT samples, [183] only a few chirality‐enriched samples are commercially available. Different separation and purification methods have been developed. They range from density gradient centrifugation, [184] gel chromatography, [185] ion‐exchange chromatography, [55] and aqueous two‐phase extraction [186] to wrappings of special macromolecules that preferably solubilize certain chiralities.[ 22 , 187 ] What they all have in common is that the resulting pure chiralities are solubilized in certain polymers or surfactants. However, for a biosensing application it is necessary to tailor the surface chemistry. Therefore, straightforward processes are required that yield chirality‐pure SWCNTs with tunable functionalization. [121]

The first ratiometric SWCNT‐based sensor was demonstrated by Giraldo et al., who integrated into the leaves of plants two sensors: one for the detection of H2O2 and one for NO. [20] The sensor system was based on the ratio of the distinct emission bands of two chirality species (Figure 21 a). Whereas the (GT)15‐(7,6)‐SWCNT‐based sensor was quenched by 20 % within 10  min in the presence of 100 μm H2O2, the reference sensor remained mostly invariant to the analyte. The overall sensor response was similar to in vitro tests.

Figure 21.

Figure 21

Ratiometric sensing. a) NIR fluorescence of (GT)15‐(7,6)‐SWCNTs in response to H2O2 compared to the nearly invariant (AT)15‐(6,5)‐SWCNT reference at different time points. Reprinted from Ref. [20] with permission. b,c) Ratiometric sensing of dopamine and H2O2 using PEG‐PL as a reference and (GT)40‐SWCNTs or SWCNTs functionalized with the hemin‐binding aptamer (HeApta). The reference sensor can be made from different colors of SWCNTs ((6,5) or (7,6) chirality). Adapted from Ref. [49] with permission. Copyright 2021 American Chemical Society.

Most recently, Nißler et al. combined the isolation of specific SWCNTs and their subsequent functionalization for the detection of neurotransmitters and other small molecules. [49] They used aqueous two‐phase extraction to obtain chirality‐pure (6,5)‐, (7,5)‐, (9,4)‐, and (7,6)‐SWCNTs and applied a surface exchange through dialysis to remove the DOC wrapping of the SWCNTs and replace it with specific ssDNA sequences or aptamers. This approach enabled the fabrication of ratiometric sensors, for example, for the detection of dopamine and H2O2 (Figure 22 b,c). For these sensors, SWCNTs were functionalized either with a (GT)40 sequence or, in the case of H2O2 detection, with an aptamer (hemin binding aptamer, HeApta) that binds the protoporphyrin hemin and catalyzes the decomposition of H2O2. PEG‐PL‐functionalized SWCNTs of another chirality served as an invariant reference. These examples show the potential of ratiometric or multiplexed sensing and given the large wavelength range of SWCNT fluorescence, there are plenty of opportunities for advanced sensing schemes.

3.4.3. Remote Imaging and Alternative Excitation Pathways

Remote imaging—the spatial separation of molecular sensors and detectors—is particularly beneficial to observe biochemical processes non‐invasively, for example, in biomanufacturing or in vivo. As only a small portion of the emitted light is captured by a camera within a certain distance to the sensors, remote detection requires either bright fluorophores or cameras with a high quantum yield in the spectral window of the fluorophore emission.

An example for remote imaging are NIR fluorescent nanosheets, which were remotely detected in a customized portable setup.[ 171 , 188 ] Due to the high brightness and emission closer to the visible range (910 nm), a low‐cost CMOS camera (Complementary Metal Oxide Semiconductor, Si based), which typically has a low quantum efficiency of around 5 % in the NIR region, could be used here.

Additionally, this setup was modified for SWCNT detection by using an NIR‐sensitive InGaAs camera, a white‐light LED, and corresponding filters for wavelength‐specific excitation and detection of emission (Figure 22 a). Up to now, remote imaging of fluorescent SWCNT‐based sensors has been used for the identification of bacteria [29] and monitoring of plant health,[ 30 , 31 , 32 , 148 ] for which resolutions in the (sub‐)millimeter range were achieved with standoff distances of up to 1 m.

Apart from exploiting the decreasing sensitivity of Si‐detectors in the NIR, efforts have been made to promote NIR‐fluorescent transducers using straightforward designs for inexpensive NIR fluorimeters. [167] Instead of using high‐cost InGaAs photodiode arrays, single InGaAs diodes were combined with a motorized stage controlled with an open source programming language. The robustness of these devices outside of the laboratory was demonstrated in a high‐throughput format with field‐side measurements of soil samples. Future developments might also show remote detection using pure (6,4)‐SWCNTs with Si‐based cameras and also versatile use as smart surfaces, for example, for monitoring contamination with pathogens, such as bacteria, on medical surfaces or even implants.

Fluorophore brightness is not the only performance‐related factor when measurements in live biological tissues are carried out. Fluorophore stability as well as wavelength‐dependent tissue scattering, absorption, and the background originating from autofluoresence must also be considered. From this point of view, SWCNTs have excellent photophysical properties.

However, imaging at the single molecule level is always accompanied by considerations to achieve a high signal to noise ratio. Long‐term single SWCNT imaging has, in particular, become established for (6,5)‐SWCNTs in living cells [191] and brain tissue. [192]

Although the second‐order excitonic transition, E22 (S22), is typically used for excitation, alternative excitation pathways such as the K‐momentum exciton‐phonon sideband (KSB) excitation [193] and up‐conversion excitation [194] have been successfully demonstrated, but excitation efficiency, photostability, as well as absorption and scattering of molecules in tissue differ depending on the excitation wavelength. Danné et al. evaluated the different excitation options (Figure 22 b) for optimal single (6,5)‐SWCNT imaging. [189] Here, E22 excitation of PEG‐PL SWCNTs was found to be four times more efficient than KSB excitation and an order of magnitude more efficient than 1064 nm up‐conversion excitation, while the signal to noise ratio was more than five times higher for KSB and up‐conversion excitation. However, the excitation at the E22 transition is not ideal due to limited tissue penetration depth and autofluorescence. In addition, simulations to quantify the impact of tissue absorption showed that a higher temperature rise of the tissue induced by up‐conversion excitation might be an issue, thus suggesting that KSB excitation is the best choice when considering all the factors. Nevertheless, it still requires relatively high excitation doses in the kW cm−2 regime.

Recently, single SWCNT imaging was performed in brain tissue in vivo by using ultralow excitation doses of 0.1 kW cm−2 (Figure 22 c). [190] To achieve this, sp3 defects were introduced into (6,5)‐SWCNTs, which lead to a fluorescence emission at E11 * (1160 nm) when exciting at the first‐order excitonic transition E11 (985 nm). This approach is beneficial as a result of excitation in the NIR window, but also because of the increased brightness by channeling free excitons to defect sites and subsequent E11 * emission.

Another way to both excite and detect in the NIR region is the use of multiphoton microscopy. This technique relies on the nonlinear excitation of at least two photons and is optimal for in vivo tissue applications when using NIR radiation. Del Bonis‐O′Donnell et al. demonstrated two‐photon 1560 nm excitation of dopamine‐sensitive SWCNT‐based sensors, which showed only 4 % scattering (one‐photon excitation: 42 % scattering). [195] However, the frame rate is significantly reduced for single sensor imaging compared to wide‐field one‐photon excitation. [196]

3.4.4. Hyperspectral and Spinning Disc Microscopy

Hyperspectral microscopy (i. e. simultaneous imaging at different wavelengths) provides another approach to exploit the spectral variety for multiplexed SWCNT imaging. Roxbury et al. resolved up to 17 distinct chiralities with single nanotube spatial resolution. [197] In contrast to organic fluorophores, more chiralities can be imaged simultaneously in a certain emission window due to the narrow emission bands of SWCNTs. The hyperspectral imaging is based on the use of a volume Bragg grating (VBG) placed between the emission port of an inverted fluorescence microscope and the NIR camera. The VBG filters one specific emission wavelength depending on optical properties such as the incident angle θ and the grating period Λ (Figure 23 a).

Figure 23.

Figure 23

Advances in spatial and spectral resolution. a) A Volume Bragg grating filters one specific emission wavelength depending on the incident angle θ, refractive index n, and grating period Λ, which enables hyperspectral imaging. b) Detection of 12 different SWCNT chiralities without deconvolution in live human cervical cancer cells. Reprinted from Ref. [197] with permission. c) Improved NIR image contrast of NIR fluorescent beads with a spinning disc NIR fluorescence microscope in comparison to wide‐field microscopy. Reprinted from Ref. [198] with permission.

The spatial imaging of different chiralities is then achieved by measuring a continuous stack of 152 images within a time frame of 20 s and 10 min depending on the signal intensity and, thus, the integration time. By using this approach 12 different chiralities from DOC‐SWCNTs in live human cervical cancer cells could be detected (Figure 23 b). Additionally, individual SWCNTs adsorbed on a surface in live mammalian cells, murine tissues ex vivo, and zebrafish endothelium in vivo were imaged.

Another challenge of typical wide‐field microscopy setups is the poor z‐resolution. To improve this limitation, a NIR spinning‐disc confocal laser microscope with an increased resolution and imaging contrast was demonstrated by Zubkovs et al. (Figure 23 c). [198] The custom‐built microscope was based on a spinning‐disc module integrated between a cooled InGaAs camera and the microscope body, which rejects out of focus light.

To achieve a maximized photon intensity, the lenses in the spinning disc unit were optimized for the NIR region. The authors showed in different biological applications the advantages of an improved lateral/axial resolution of 0.5±0.1 μm /0.6±0.1 μm (enhancement of 17 % /45 %) compared to the wide‐field configuration, reaching from single‐particle tracking over the spatial distribution of nanoparticles within an organelle to the optical in situ monitoring of glucose by GOx‐SWCNT‐based sensors embedded within an agarose gel. Overall, this approach showcases the opportunities for in vitro and in vivo imaging and sensing with improved spatiotemporal resolution.

4. Outlook and Perspectives

SWCNTs have shown their large potential as versatile building block for biosensors. The last few years have provided fundamental mechanistic insights, novel recations, and novel applications such as sensing in plants or primary cells. The advent of covalent quantum defect chemistry as well as the broader availability of monochiral samples will further advance typical figures of merit such as selectivity and robustness in demanding biochemical environments. One of the key challenges remains a basic understanding of molecular recognition and also signal transduction in the organic phase around these materials. Advances in this space can directly translate into superior selectivities. Additionally, high‐throughput or screening approaches will increase the speed of chemical discoveries. This is particularly interesting for applications in complex biological environments, where interactions become too complex to be predicted. Several milestones remain to be achieved before transfer into commercially available products. In vivo applications require long‐term evaluation of each sensor's toxicology and stability profile. Here, new covalent quantum defect functionalization strategies as well as the standardization of protocols and the purity of SWCNTs offer promising opportunities. Additionally, higher degrees of multiplexing and the adaptation of conventional cameras and readout systems will increase the application potential of SWCNT‐based sensors. In summary, SWCNT‐based biosensors offer a rich playground for chemistry and related disciplines and promise further advances and breakthroughs in the near future.

Appendix

Table 1, 2, 3, 4, 5, 6, 7, 8, 9

Table 2.

Detailed overview of fluorescent SWCNT‐based sensors for neurotransmitters.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial

resolution

Temporal

resolution

Reversibility

Dopamine (DA)[15]

In PBS, immobilized

Screening approach:

(GT)15‐SWCNTs and other candidates

FI increase

Depending on chirality

LOD in solution 11 nm

Response to other catecholamines with different magnitude

HiPCO

(6,5) at 991 nm, (7,5) at 1044 nm, (10,2) at 1077 nm, (9,4) at 1132 nm, (8,6) at 1203 nm

Single sensor

4 pixels, 585 nm × 585 nm**

Real time

Within

seconds

Yes

Reducing and oxidizing molecules, e.g. ascorbic acid/oxidized ascorbic acid, cysteine/cystine, DA, epinephrine (EPI), glutathione/oxidized glutathione, riboflavin, trolox[63]

In PBS

FI increase with negatively charged polymer wrapping (e.g. ssDNA, poly(acrylic acid))

FI decrease with positively charged wrapping (polyallylamine‐SWCNTs)

No FI change with PL‐PEG‐SWCNTs

100 μm tested

Polymer‐wrapped SWCNTs that respond to reducing molecules (e.g. +141%, ascorbic acid) also respond to oxidizing molecules (e.g. 81%, riboflavin)

Up to 250% FI increase with reducing molecules such as ascorbic acid, EPI, trolox with negatively charged wrapping, but redox potential alone cannot explain FI changes

Different responses for different small molecules

CoMoCAT

(6,4), (8,3), (9,1), (6,5), (7,5)

800—1050 nm

ND

ND

ND

Catecholamine (DA, EPI, norepinephrine (NE), amino acids, saccharides, riboflavin[202]

In PBS

ssDNA‐SWCNTs (24 sequences tested, e.g. (ATT)4, (TAT)4, (ATTT)3)

FI increase for catecholamines and ascorbic acid

Chirality‐dependent FI change, e.g. smaller diameter SWCNTs with (TAT)4 wrappings are less responsive than larger diameter SWCNTs

Different responses for different small molecules

HiPCO

(8,3), (6,5), (7,5), (10,2), (9,4), (7,6), (12,1), (11,3)

ND

ND

ND

DA[100]

Collagen‐coated SWCNTs for increased cell adhesion, immobilized on glass, PC12 neuroprogenitor cells cultivated on top

Screening approach:

(GA)15‐SWCNTs

FI increase

Interaction of hydroxy groups of DA with phosphate groups of DNA backbone pulls phosphate groups closer to the SWCNT surface, which increases the FI.

Single molecule

LOD 100 pm

Not over catecholamine homologues (e.g. EPI, NE, l‐ascorbic acid), but PC12 cells mainly release dopamine

(6,5)‐enriched chiralities

(6,5) at 980 nm

>20,000 sensors per cell

850 nm pixel size**

<100 ms

Yes

Catecholamine (DA, EPI, NE)[118]

In PBS, DA in presence of NE

Screening approach:

different ssDNA‐SWCNTs, e.g. A30, (GT)10, (GC)15, (AT)15, (GT)10, for different selectivity and sensitivity

FI increase

(GT)10‐SWCNTs for sensing DA in presence of NE

LOD mostly in single‐digit nm regime

LOD of dopamine in presence of NE 4.9 nm, without NE 0.1 nm

Dissociation constants vary between 2.3 nm ((GC)15‐SWCNTs + NE) and 9.4 μm ((AT)15‐SWCNTs + DA)

(6,5)‐enriched at 987 nm

Single nanosensor

Real time

Within

seconds

Yes

Catecholamine release, e.g. DA[120]

Brain slices from dorsal striatum of mouse incubated in artificial cerebrospinal fluid (ACSF)

(GT)6‐SWCNT

FI increase

10 nm—100 μm

Over γ‐aminobutyric acid, glutamate, acetylcholine

In the presence of pharmacological DA receptor ligands

Not for DA over NE

HiPCO

(9,4) at 1128 nm

μm

Sub‐second

Yes

DA[121]

In PBS

(GT)10‐SWCNTs

FI increase

>20% intensity increase (100 nm)

ND

Monochiral (6,5) at 980 nm

ND

ND

ND

DA, riboflavin, H2O2, pH[176]

In PBS

ssDNA‐SWCNTs, e.g. (GT)5, (GT)15, A30, T30, C30

In most cases FI change does not correlate with the number of adsorbed ssDNA molecules

Different responses for different small molecules

CoMoCAT

ND

ND

ND

DA[203]

Acute mouse brain slices in ACSF, electrically evoked neurotransmitter release

PEG2000‐PL‐(GT)6‐SWCNTs

FI increase

Improved sensor response due to PL‐induced quenching of SWCNT baseline FI

In vitro: increased sensor response to 200 μm DA of ΔI/I 0=2.01 compared to nonpassivated sensors ΔI/I 0=1.44

Ex vivo in brain slices: increased responsivity by 52±8 % and improved number of identified ROI by 160±50 %

Reduced protein adsorption of 28% compared to nonpassivated sensors

HiPCO

Sub‐μm

Real time

111 ms**

Yes

DA[80]

Self‐assembled on neutravidin‐coated microscopy slides

Screening approach:

Combination of covalent and noncovalent SWCNT functionalization

(GT)15‐amine‐PEG2k‐biotin‐SWCNTs

(GT)15 is able to detect DA, while biotin is able to detect neutravidin and streptavidin

ΔI/I 0=0.8658±0.1986 for 25 μm DA

ND

HiPCO

(10,2) at 1053 nm

ND

Real time

Sub‐seconds

Yes

DA, H2O2 [139]

SWCNT uptake, transport, and programmed release by human immune cells (neutrophilic granulocytes, neutrophils)

DA: (GT)15‐SWCNTs, FI increase

H2O2: Heminaptamer‐SWCNTs, FI decrease

100 nm DA and 100 μm H2O2 tested

Sensors functional after cargo transport and release

ND

CoMoCAT

ND

Within seconds

ND

DA[136]

Immobilized on surface in complex medium (e.g. Schneider's medium)

In presence of CaCl2, Drosophila neurons

Locked nucleic acid bases incorporated into (GT)15 sequence

LOD 10 nm

Superior compared to (GT)15‐SWCNTs in presence of CaCl2/Schneider's medium

Over Ca2+

HiPCO

(7,5), (7,6)

ND

Measurement after 5 min—24 h

ND

DA, NE[119]

In PBS, NaCl, protein‐rich media (DMEM + 10 % fetal bovine serum (FBS)) and ACSF

Screening approach of (GT)x sequences:

(GT)6‐SWCNTs

FI increase

Down to 100 nm tested

3500%/2300% increase to 100 μm NE/DA in PBS

143%/260% increase to 100 μm DA in DMEM + FBS/ ACSF

Over acetylcholine, serotonin, histamine, γ‐aminobutyric acid, glutamate, glycine, aspartate, DA transporter inhibitor nomifensine, DA receptor agonist quinpirole, antagonist sulpiride, and haloperidol

HiPCO

(9,4) at 1127 nm

ND

Measurement after 5 min/1 h of analyte incubation

ND

DA, riboflavin, pH, H2O2 [49]

Immobilized

DA: (GT)40‐SWCNTs,

Riboflavin: (GT)40‐SWCNTs,

pH: PEG‐PL‐SWCNTs,

H2O2: hemin‐binding aptamer‐SWCNTs

Higher brightness of monochiral sensors, μm range for H2O2 detection

Affected by surfactant residues, differences in sensing magnitudes for different sequences/analytes

Monochiral (6,5) at 990 nm, (7,6) at 1130 nm

ND

ND

ND

DA[135]

Release from primary neurons (varicosities) using a sensor paint (AndromeDA)

(GT)10‐SWCNTs

FI increase

Sensors are applied on top of cells as sensor coating/paint (AnromeDA)

1 nm–100 μm

EC50: 299 nm

Over neurons treated with inhibitor reserpine (depletes DA)

CoMoCat

Subcellular

Discriminates individual varicosities (up to 100 within a single imaging field)

Real time

15 images s−1

Yes

Serotonin[27]

Release from human blood platelets

Serotonin‐binding‐aptamer‐SWCNTs

Fl increase

100 nm—10 μm

Over tryptophan, histamine, tyrosine, glucose

11 % increase to 100 nm DA compared to 45 % increase to serotonin

(6,5)‐enriched chiralities

(6,5) at 995 nm

Subcellular

63 nm pixel size**

Real time

(Sub)second

Yes

Serotonin[134]

Acute striatal brain slices of mice and exogenous addition of serotonin

Screening approach:

Identification of polynucleotides by exponential enrichment for selective ssDNA‐SWCNTs

100 nm—50 μm

Over serotonin analogues, metabolites, and receptor‐targeting drugs (e.g. 5‐hydroxytryptophan, 5‐methoxytryptophan, fluoxetine)

FI increase due to DA of 1400 %

HiPCO

(8,6) at 1195 nm

Sub‐μm

Real time

(Sub)second

Yes

[a] FI: fluorescence intensity, ND: not determined, **: limited by the Abbe limit, diffusion and detection speed.

Table 3.

Detailed overview of fluorescent SWCNT‐based sensors for other small molecules.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial resolution

Temporal resolution

Reversibil‐ity

Acetic acid[145]

In DI water, wine

Analytes injected into glass bottle with inlet and outlet tubes

Screening approach:

Peptide‐encapsulated SWCNTs (YK‐SWCNT) detect volatile molecules

Synthesized peptide (YK): contains positive charge to potentially improve acetic acid binding to the sensor and aromatic amino acids to enhance π‐π interaction and binding to SWCNTs

FI decrease

In DI water: concentrations of 0.05 %–3.2 % (v/v) tested

In wine: 0.05 % and 0.1 % (v/v) tested

Slightly increased sensor response at higher humidity results in stronger quenching due to additional binding of water molecules to the sensor

In wine, other volatile compounds interfere with sensor

CoMoCAT

(6,5) at 970–1050 nm

ND

Real time

Steady state after 40 s

In wine: no steady state after 90 s, but significant FI change

Yes, but slow.

Illumination with UV light enhances recovery speed

Adenosine‐5’‐triphosphate (ATP)[140]

In Tris‐HCl buffer, cellular ATP detection in living HeLa cells

Rational approach:

PL‐PEG‐functionalized SWCNT/luciferase enzyme conjugate

FI quenched by the luciferase‐mediated bioluminescence reaction product oxyluciferin in the presence of ATP and d‐luciferin

LOD 240 nm

Over Adenosine 5’‐monophosphate, adenosine 5’‐diphosphate, cytidine 5’‐triphosphate, guanosine 5’‐triphosphate

Chirality mix

μm

Real time

Measurement after 15 min of analyte addition

No

DA, riboflavin, pH, H2O2 [49]

Immobilized

DA: (GT)40‐SWCNTs

Riboflavin: (GT)40‐SWCNTs

pH: PEG‐PL‐SWCNTs

H2O2: hemin‐binding aptamer‐SWCNTs

Higher brightness of monochiral sensors, μm range for H2O2 detection

Affected by surfactant residues, differences in sensing magnitudes for different sequences/analytes

Monochiral (6,5) at 990 nm, (7,6) at 1130 nm

ND

ND

ND

Doxorubicin[143]

In water or water/DMSO mixture, human blood plasma, mouse tissue

Screening approach:

CCCCCCCCAGAATTACTTCCCCCCCC‐SWCNTs

FI change and red‐shift (shift for readout)

LOD 8 μm

Over dacarbazine (chemotherapeutic, commonly co‐injected with doxorubicin)

Not over other anthracycline chemotherapeutic drugs (epirubicin, daunorubicin)

Chirality mix

(7,6), (6,5)

ND

Steady state within minutes

20 min for diffusion of doxorubicin into tissue

Yes

Doxorubicin[115]

In saline‐sodium citrate buffer, FBS, intracellularly (incubated in Raw 264.7 murine macrophage cells), incorporated into membrane and implanted into peritoneal cavity of living mice

(GT)15‐SWCNTs

FI decrease and red‐shift

In buffer: 500 nm–50 μm

In serum: LOD 5 μm

In vivo: LOD 50 μm

Not over other DNA‐intercalating agents (SYBR green, Hoechst 33258, ethidium bromide, 1‐pyrenebutyric acid)

HiPCO

(9,4)

Sub‐μm

Real time

Within minutes

No

Human steroid hormones (cortisol, progesterone)[144]

In DMSO, PBS, 10% mouse serum, subcutaneously implanted in mice (progesterone detection, SWCNTs in HG)

Semirational approach:

Cortisol sensor: p(AA197‐ran‐AC5)‐SWCNTS

Progesterone sensor: p(AA53‐ran‐S22‐ran‐AC4)‐SWCNT

FI increase

In solution: cortisol:

10–100 μm, progesterone: 5–100 μm

In serum: 12 % fluorescence increase at 100 μm progesterone

In HGs inside dialysis bag: three times higher sensor response (22.1 %) compared to control

Over other steroids by a factor of 2

Progesterone additionally over other small molecules and large proteins

HiPCO

(6,5) for cortisol sensor, (7,6) for progesterone sensor

Sub‐mm

3 h needed for stabilization of fluorescence signal in HG

Yes

Nitroaromatics[141]

In solution, immobilized on glass in Tris buffer

Screening approach:

Bombolitin II‐SWNTs

Wavelength shift

(AT)15‐SWCNTs for TNT detection

FI changes in discrete quenching steps

Single molecule

Distinction with PCA possible: over several containing nitroaromatic and non‐aromatic compounds containing nitro groups, e.g. picric acid, cyclotrimethylenetrinitramine, 2,4‐dinitrophenol, over other nitroaromatics (e.g. RDX, TFM) but 2,4‐dinitrotoluene and 2‐nitrophenol show quenching to a lesser degree

HiPCO

Analyzation of 8 chiralities, e.g. (7,5), (11,3)

Single molecular

Real time

500 ms–1 s

Yes

Nitroaromatics/picric acid[30]

Within spinach plant leaf mesophyll by root uptake or through direct uptake through leaf surface

Bombolitin II‐SWCNTs

FI quenching

85 %/78 % quenching with 400 μm picric acid by root/leaf uptake

ND

HiPCO

(6,5)‐enriched chiralities

0.5 mm pixel size for a stand‐off distance of 0.85 m

Real time

5–15 min transport time of picric acid uptake from the roots to the leaves, 40–50 min for saturation

Sensor response after 10 s by leaf uptake

No

Odors, volatile molecules[146]

Alcoholic vapors (ethanol, methanol, propanol, 2‐propanol)

Distinction between aromas of red wine, beer, vodka

Distinction between limonene, undecanal, and geraniol vapors

Analytes injected into glass bottle with inlet and outlet tubes

Array of five different peptide‐encapsulated SWCNTs adsorbed on a nitrocellulose paper, recognition by LDA and machine learning

FI increase

LOD around 216 ppm of

ethanol

Slightly increased sensor response at higher humidity

Discrimination of a mixture of ethanol and methanol

CoMoCAT

(6,5) at 1000 nm

ND

Real time

Response within seconds

Steady state after 24 s, some continue to rise after 45 s

Yes, within 160 s

Phosphodiesterase type 5 (PDE5) inhibitor Vardenafil[147]

In PBS

Screening approach:

Poly(methacrylic acid‐co‐styrene)‐SWCNTs with methacrylic acid and styrene at 90:10 ratio

Synthetic corona mimics H loop of native enzyme PDE5

FI decrease

LOD 0.02–0.2 μm by varying the polymer length

Sensor has smaller binding affinity than the enzyme, interaction is disrupted in the presence of PDE5a

Over 22 tested small molecules, not over inhibitor Sildenafil (chemical similar), but smaller emission modulation

HiPCO

(8,3), (6,5)

ND

5 min incubation time

ND

Polyphenols (tannins, flavonoids, …)[148]

In plant extracts, tissue culture media

Sensors embedded in agar, pathogen‐induced release from soybean roots (stimulated with pathogen‐derived elicitor or mechanical wounding)

PEG‐PL‐SWCNTs

FI decrease, red‐shift

K d=90 nm, saturation in lower μm range (−80 % FI change, 20 nm wavelength shift)

Differences for different polyphenols

Over potential interferant molecules from the root such as sugar, H2O2

CoMoCAT, HiPCO, and monochiral (6,5)

Sub‐mm with standoff detection

Real time (s)

ND

Porphyrins/ heme[204]

Detection of plasma samples with solvent extraction method

Heme‐binding‐aptamer‐SWCNTs

FI decrease

LOD 20 nm

Over other porphyrins, BSA, lysozyme, phthalocyanine

CoMoCAT

(7,5)

ND

Real time

Immediately

ND

Riboflavin, l‐thyroxine, oestradiol[70]

In buffer

Riboflavin imaging in live Raw 264.7 macrophage cells

Screening approach:

Oestradiol: Rhodamine isothiocyanate‐difunctionalized poly(ethylene glycol)‐SWCNTs

FI decrease

l‐thyroxine: Fmoc‐l‐phenylalanine PEG‐SWCNTs

FI decrease

Aliphatic chain and Fmoc group adsorb onto SWCNT, strong interaction between Fmoc and l‐thyroxine leads to molecular recognition

Riboflavin: 53 mol/mol boronic‐acid‐substituted phenoxydextran‐wrapped‐SWCNTs (BA‐PhO‐Dex‐SWCNTs)

Red‐shift through polymer dielectric change

0.6 FI change to 100 μm oestradiol/l‐thyroxine and 11 nm shift to riboflavin

Over 35 biological molecules

Chirality mix

Deconvoluted into 8 chiralities

(7,6) at 1147 nm for tracking of riboflavin in macrophage cells

Sub‐μm

In macrophage cells within seconds

Yes, for riboflavin through riboflavin‐binding protein

Riboflavin[113]

SWCNTs embedded in HG with water and barium chloride, subcutaneously implanted into mice

(GT)15‐SWCNTs

FI decrease

10 mm riboflavin results in 48 % quenching for HG SWCNTs with a concentration of 10 mg L−1

LOD in 5.4 mm depth tissue

Pore size of HG can be engineered to exclude large molecular weight interfering molecules, average pore size: 3.2 nm

(6,5)‐enriched SWCNTs

(6,5)

Sub‐mm

Two characteristic quenching times: 14.1 min (riboflavin‐SWCNT reaction), 5.8 h (riboflavin diffusion) for HGs with 10 mg L−1 SWCNT concentration

ND

Riboflavin[142]

In HG for in vitro and ex vivo tissue measurement of marine organisms (Sparus aurata, Stenotomus chrysops, Galeus melastormus)

(AC)15‐SWCNTs

FI decrease

In vitro: 1–100 μm

in vivo: LOD in 7 mm skin and muscle tissue

Pore size of HG can be engineered to exclude large molecular weight interfering molecules, average pore size: 15 nm

CoMoCAT

mm

In vitro: immediate response, fluorescence decreases continuously while riboflavin diffuses to sensors

ND

[a] FI: fluorescence intensity, ND: not determined, HG: hydrogel.

Table 4.

Detailed overview of fluorescent SWCNT based sensors for lipids.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial resolution

Temporal resolution

Reversibility

Endolysosomal lipids[117]

In PBS, in fibroblasts from an NPC patient (Niemann‐Pick type C, lysosomal storage disease)

Screening approach:

(GT)6‐SWCNTs

Wavelength shift

For lipid analogues, e.g. PEG‐cholesterol: 10 nm—1 μm

Over BSA, double‐stranded DNA from salmon, carboxymethyl cellulose (CMC)

HiPCO

(8,6) at 1200 nm

Subcellular

< 2 min for incubation of fibroblasts from NPC patient with SWCNTs

Measurement after 24 h

Yes, upon administration of a drug (hydroxypropyl‐β‐cyclodextrin) that reverses disease phenotype

Endolysosomal lipids[149]

In cell culture medium with 10 % FBS, intravenous injected into mice with NPA/B and NPC disease to detect lipid accumulation in the Kupffer cell endolysosomal organelles

Screening approach:

CTTC3TTC‐SWCNTs

Blue‐shift

In cell culture medium 6–8 nm blue shift

In vivo 4.2–5.3 nm blue shift

Minimal response to BSA, genomic DNA, CMC

Not over different lipid types

Chirality mix

(9,4) at 1125 nm

μm

Within min–h

ND

[a] FI: fluorescence intensity, ND: not determined.

Table 5.

Detailed overview of fluorescent SWCNT based sensors for proteins.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial resolution

Temporal

resolution

Reversibility

β‐Carotene[116]

In canola oil

Screening approach:

(GT)15‐SWCNTs adsorbed onto nitrocellulose paper

Dissociation constant 2.2 μm

Less FI increase to fat‐soluble vitamins (menadione, retinyl acetate and α‐tocopherol)

CoMoCAT

ND

Real time

ND

Aggregation status of human IgG[159]

In HG

Chitosan‐SWCNTs modified with

Cu2+‐NTA/His‐tagged protein A interacting with human IgG leading to ion based proximity quenching

LOD below 660 nm

ND

CoMoCAT

(6,5)

mm

Real time

Within 5 min

Usable twice

Albumin[152]

In clinical urine samples of patients with microalbuminuria

Samples need to be filtered to remove small interfering molecules

Screening approach:

Constructed polymer mimics fatty binding to albumin

Carboxylate‐functionalized polycarbodiimide polymer‐SWCNTs incorporated into acrylic‐based paint

Blue‐shift, FI increase

LOD 3 mg L−1

Potential interfering proteins such as transferrin, γ‐globulins, degraded albumin showed either negligible change or red‐shift

HiPCO

(9,4)

ND

Saturation after 20 min

FI change: 0.214 min−1

Wavelength change: 0.1845 min−1

ND

Avidin

In solution

SWCNTs noncovalently bound to dye‐ligand conjugates (biotinylated anthracene), which are covalently bound to a biological receptor ligand (biotin), which binds to the analyte

FI increase

LOD 1–5 nm

Response to BSA, but with three orders less sensitivity

HiPCO

900—1500 nm

ND

ND

Yes

Cardiac

biomarker troponin T[64]

In HG

Rational approach:

Chitosan‐wrapped SWCNTs noncovalently modified with troponin antibody using a Ni2+‐NTA/hexahistidine‐tagged protein mechanism for divalent ion‐based proximity quenching

FI increase

LOD 2.5 nm

Over BSA, IgG, cancer biomarker Pisum sativum agglutinin (PSA), 10000 times diluted human plasma (7 μg mL−1 proteins)

Affected by viscosity change (e.g. 100 times diluted plasma), unable to quantitatively detect in full plasma

Chirality mix

1000–1400 nm

ND

Real time

Within 5 min saturation

Yes

Cell surface receptors

CD20, HER2/neu[205]

Incubation of cells in SWCNT solution

Rational approach:

PL‐PEG‐NH2‐SWCNTs conjugated to antibodies

Rituxan antibody to recognize CD20 cell surface receptor on

B‐cell lymphoma

Herceptin to recognize HER2/neu positive breast cancer cells

ND

Rituxan‐SWCNTs: over T‐cell

lymphoma

Herceptin‐SWCNTs: over HER2/neu negative cell line

HiPCO

900–2200 nm

Sub‐μm

1 h incubation time before measurement

ND

Electrostatic charge accumulation mediated by cell membrane proteins[206]

SWCNTs in contact with cell monolayer (HeLa cells, murine fibroblast cell line (NIH/3T3), human lymphocyte cell line (Jurkat))

(AT)15‐SWCNTs

Wavelength shift

Determined between membrane‐bound SWCNTs and SWCNTs in serum‐free solution

Emission energy correlated with the degree to which a cell adheres to a substrate and the zeta potential of the cell

Jurkat cells: Δλ=6.02±0.28 nm

NIH/3T3: Δλ=4.97±0.23 nm

HeLa cell: Δλ=2.72±0.12 nm

Cell type dependent trend

HiPCO

900–1600 nm

20 μm pixel size**

ND

ND

Fibrinogen[71]

In serum (10% FBS in PBS)

Screening approach:

Dipalmitoyl‐phosphatidylethanolamine (DPPE)‐PEG (5 kDa)‐SWCNT

Lowest concentration tested 0.05 mg ml−1

Negligible response of < 5 % intensity to 13 proteins (some are highly abundant in blood and others are relatively rare but of clinical significance)

HiPCO

(9,4), (7,6)

Single sensor

Real time

Signal quenching occurs rapidly (within seconds),

Saturation within minutes

ND

Glutathione‐S‐transferase (GST) fusion proteins[154]

In solution

Glutathione‐(TAT)6‐SWCNTs

Modulation of FI and wavelength in response to GST and GST fusions depending on SWCNT structure

LOD 10 nm

Responds to multiple classes of GST‐tagged proteins (e.g. cell‐cycle proteins, RNA‐binding proteins, ovarian cancer protein

biomarkers)

Affected by powdered milk (protein blocking agent), BSA

HiPCO

(8,6), (9,1)

ND

Real time

5 min incubation time

ND

Green fluorescent protein (GFP), GFP‐fusion proteins[79]

Incubation with GFP

GFP‐binding nanobody‐SWCNTs, covalently bound aryl maleimide

Quantum defects introduced by light‐driven diazonium chemistry serve as anchor points for peptides and proteins, conjugation of cysteine‐containing proteins to maleimide

ND

Over negative control, where no diazonium salt was added

E11 * at 1135 nm

μm

ND

ND

Gynecologic cancer biomarker

human epididymis protein 4, cancer antigen 125, chitinase‐3‐like protein, mesothelin[160]

In 10% FBS, uterine lavage samples

Machine‐perception‐based sensor array consisting of 132 distinct DNA‐SWCNT complexes:

11 ssDNA‐SWCNT‐based sensors with 12 chiralities, e.g. (AT)11‐, (GT)12‐, (ATT)4, (TCT)5‐SWCNTs

FI increase/decrease and wavelength shift

LOD in pm range

Simultaneous distinction/ detection of biomarkers with classification accuracy (F1‐score) of ca. 0.95

HiPCO

Deconvoluted to extract individual chiralities, e.g. (6,5), (8,4), (10,3), (7,5), (7,6), (8,3)

ND

ND

ND

Human α‐thrombin[207]

In PBS

Rational approach:

Dye (FAM) labelled human α‐thrombin binding aptamer‐SWCNTs

FI increase

LOD 1.8 nm

Dynamic range 4–150 nm

In presence of 100 nm of other proteins (BSA, HAS, IgG)

HiPCO

ND

Incubation of target 2–3 h

ND

Immunoglobulin IgG[104]

In HG

Rational approach:

Chitosan‐wrapped SWCNT noncovalently modified with immunoglobulin‐binding proteins A using a Cu2+‐NTA/His‐tagged protein mechanism for divalent ion based proximity quenching

FI increase

LOD 10 ng mL−1

ND

HiPCO

ND

Real time

Within seconds

Equilibrium reached within 5 min

ND

Immunoglobulin (human IgG, mouse IgM, rat IgG2a, human IgD)[151]

Ink printed

Rational approach:

Chitosan‐SWCNTs noncovalently modified with immunoglobulin‐binding proteins.

Cu‐NTA chelating chemistry with histidine tag for divalent ion based proximity quenching

Binding proteins: protein A, protein G, protein L

FI increase

LOD 25 μg mL−1 of human IgG,

2.5 μg mL−1 at 20x magnification

Different association constants for different antibody/binding proteins

CoMoCAT

(6,5) at 980 nm

Sub‐mm

Real time

1 s**

Response within seconds

Yes

Insulin[155]

In buffer

Insulin‐binding aptamer‐SWCNTs

FI quenching

Lowest concentration tested: 9 nm

Over BSA, proteinase K

HiPCO

(6,5)

Sub‐μm

ND

ND

Insulin[156]

In collagen extracellular matrix

Insulin secreted by pancreatic β‐ cells due to glucose addition

Insulin‐binding aptamer‐SWCNTs

FI quenching upon analyte binding by photoinduced charge‐transfer mechanism (electron transfer from conduction band of SWCNTs to LUMO of the bound insulin)

LOD 10 nm

Over BSA, proteinase K, cell culture media RPMI 1640, glucose

CoMoCAT

(7,5) at 1044 nm

Sub‐μm

Real time

Within seconds

FI quenching rate 5.85×1014m −1s−1

diffusion reaction rate 0.129 s−1

Yes, through enzymatic proteolysis within 1 h

enzyme: α‐chymotrypsin

Insulin[101]

In PBS, blood serum (10 % FBS in PBS)

Screening approach of PEG‐conjugated lipids

C16‐PEG(2000 Da)‐ceramide‐SWCNTs

FI decrease

180 pm—3.5 μm tested

In FBS reduced response

Over library of proteins (< 5 % intensity change)

Not over apolipoproein A‐I and longer fragments of isolated α‐ and β‐peptide chains of insulin

HiPCO

(10,2)

ND

Measurement after 30 min of insulin addition

ND

Insulin[158]

In PBS, Krebs‐Ringer HEPES buffer (KRHB), secreted by pancreatic β‐cells due to glucose addition

C16‐PEG(2000 Da)‐ceramide‐SWCNTs

(AT)15‐Insulin‐binding aptamer‐SWCNT

FI decrease

8.1 nm–74   mm tested

C16‐PEG‐ceramide‐SWCNTs: response stable and reproducible

(AT)15 ‐Insulin aptamer‐SWCNT: diminishing response over time, batch‐to‐batch variations

Over BSA, KRHB, IBMX, glucose

HiPCO

(10,2)

(6,5)

ND

5 min incubation time

Detection in real time

ND

Integrins[66]

Human platelet integrin αIIββ3

Immobilized on epithelial cells

Arg‐ly‐Asp (RGD) peptide conjugated to different ssDNA sequences in linear ssDNA‐RGD or bridged ssDNA‐RGD‐ssDNA geometries

Integrin affinity of RGD motif depends on its conformational freedom due to ssDNA‐RGD geometry

IC50 values varied from 309 nm for C20‐RGD‐SWCNTs to 29 nm for (GT)15‐SWCNTs

DNA sequence affects overall RGD affinity

CoMoCat

ND

ND

ND

Green fluorescent protein (GFP), GFP‐fusion proteins[67]

Tracking of motor protein (Kinesin‐5‐GFP) in embryos of Drosophila melanogaster

Rational approach:

GFP binding nanobodies conjugated to DNA‐wrapped SWCNT

GBP‐(GT)20‐SWCNTs

ND

CoMoCAT

(6,5)

Single sensor

Real time

Resolving the velocity of a molecular motor in vivo at 1340 nm s−1

ND

Ovarian cancer biomarker HE4 (human epididymis protein 4)[65]

In serum (10 % FBS), living mice, sensors loaded into semipermeable PVDF membrane capillary

Rational approach:

HE4 Antibody (Ab) is goat polyclonal anti‐HE4 IgG antibody

Ab‐(TAT)6‐amine‐SWCNT passivated with BSA

In serum: 10 nm–500 nm

Mostly over nontarget proteins like uPA, CA‐125 (another ovarian biomarker), BSA or 93 % FBS

HiPCO

900 — 1400 nm

Single sensor

Change after 1 min, stabilized signal after 1 h

ND

Prostate cancer biomarker uPA[106]

In PBS, blood, FBS, plasma

Rational approach:

Mouse monoclonal IgG anti‐uPA‐(TAT)6‐SWCNTs passivated with BSA to increase sensitivity

Red‐shift

LOD

In buffer 100 pm

In serum 25 nm

In plasma 100 nm

Increased selectivity in complex protein environment due to BSA passivation of SWCNTs

HiPCO

(9,4), (8,6), (8,7)

ND

Saturation after 30/90 min in human serum/ plasma

ND

Prostate tumors[21]

In tissues/ tissue‐like phantoms, serum (FBS), incubated on human prostate cancer cell lines, in vivo in mice (intravenous injection)

Rational approach:

Prostate specific membrane antigen (PSMA) antibody conjugated to M13‐phage SWCNTs

At 2 μg ml−1 SWCNTs detection depth up to 2.5 cm in tissue‐like phantoms

4‐fold improved uptake in PSMA positive prostate tumors compared to control, stable in serum

HiPCO

mm in vivo

After 2–4 h post injection

ND

RAP1[105]

Release from E. coli cell lysates

Rational and screening approach:

RAP1‐aptamer‐(AT)11‐SWCNT

With spacers between (AT)11 enhanced FI increase (4x) due to less adhesion of aptamer to SWCNT surface

Zeptomolar protein detection

Over eight tested other proteins

Chirality mix

(6,5)

Single cell

ms**

Yes

SARS‐CoV‐2 spike protein[157]

In saliva, viral transport medium

Rational approach:

ACE2‐(GT)6‐SWCNTs, passivation with PE‐PEG

FI increase

LOD 12.6 nm/ 104–106 viral copies per μL in solution/on surface

Less increase with other viral spike‐like proteins (SARS‐CoV‐1 S RBD, MERS S RBD, FLU hemagglutinin subunit, serum albumin), in biological fluids (e.g. saliva, viral transport medium)

HiPCO

1130 nm

ND

Within 90 min/5 s in solution/ immobilized

ND

Wheat germ agglutinin (WGA) (sugar‐binding lectin protein)[153]

Sugars/N‐acetylglutamic acid (GlcNAc) and N ‐acetylneuraminic acid (Neu5Ac)

In buffer, complex biological media, immobilized

Screening approach:

Peptoid‐SWCNT

FI decrease in response to WGA

Sensor shows preserved protein activity and is able to bind its target sugars

LOD 3.4 μm

Minor responses to protein A, BSA, NeutrAvidin, lysozyme

FI increase to peanut agglutinin, ConA

Attenuated ability to detect WGA in complex biological media (DMEM, FBS)

Over other sugars commonly bound by lectins (fructose, galactose, glucose, mannitol mannose, sucrose), but not fucose

HiPCO

(7,6)

Single sensor

Equilibrium reached within 1 h

ND

[a] FI: fluorescence intensity, ND: not determined, HG: hydrogel.

Table 6.

Detailed overview of fluorescent SWCNT based sensors for sugar.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial resolution

Temporal resolution

Reversibility

d‐glucose[24,208]

SWCNT solution loaded into dialysis capillary imaged through human epidermal tissue sample

Rational approach:

GOX‐SWCNTs with Fe(CN)6 3− addition as electroactive species results in FI decrease or Fermi level shift into the VB due to irreversible adsorption on the SWCNT surface

Addition of analyte results in increasing restored FI

GOX catalyzes the reaction of d‐glucose to d‐glucono‐1,5‐lactone with a H2O2 co‐product

LOD 34.7 μm

ND

HiPCO

μm

Within 80 s

ND

d‐glucose[108]

In PBS, immobilized

Rational approach:

Glucose‐binding protein (GBP) covalently conjugated to PVA‐SWCNTs

Quenching in discrete steps in response to glucose due to conformation change of GBP

2.5–50 mm

Linear until 10 mm

Over fructose, mannose

CoMoCAT

(8,3), (6,5), (7,5)

Single‐sensor

500 nm pixel size**

Immediately (s)

Yes

Glucose[11]

In BSA + PBS

BSA to prevent concanavalin A (ConA, lectin with four glucose‐binding sites) adsorption to the walls of the cuvette

Rational approach:

Phenoxydextran‐SWCNTs with ConA

Competitive binding between target analyte and dextran, ConA introduces protein‐controlled aggregation and FI decrease, introduction of glucose causes dissolution of aggregate and FI recovery

LOD 3.8 nm

Response range based on ConA concentration

Over glycerol (hydrogen‐bond‐breaking agent)

Chirality mix

ND

3–28 min to reach steady state

Yes

Glucose[162]

In solution, 36°C

Rational approach:

GOX‐DNA‐SWCNTs with 2 mm/5 mm potassium ferricyanide (PFC) as electron transfer mediator

FI increase

LOD 1 mm

With increasing amount of glucose portions (1–2 mm) less sensitive (FI restoration decreases)

ND

HiPCO

(9,2) at 1136 nm

ND

Within minutes

No

Glucose[68]

In solution

Screening approach:

Boronic acid derivatives complexed with SC‐SWCNTs

Identified derivatives: 4‐cyanophenylboronic acid, 4‐chlorophenylboronic acid

Blue‐shift and FI increase

5–30 mm

ND

CoMoCAT

(6,5)

ND

Within

seconds

Yes

Glucose, fructose[81]

In solution

SWCNTs locally functionalized with a phenylboronic acid group

Blue‐shift and FI decrease

13.5 nm shift with 8.8 mm fructose/19 mm glucose

ND

CoMoCAT

E11 * of (6,5) at 1138 nm

ND

ND

ND

Glucose[161]

In PBS, human serum, incorporated into membrane device

Rational approach:

GOX‐SWCNTs

FI increase

In PBS: 3 mm—30 mm tested

In serum: 3.3 mm–7.8 mm tested

Different FI increase to mannose, galactose, xylose

Over maltose, fructose

CoMoCAT

(6,5) at 995 nm

ND

Without/with membrane setup saturation after 1/12–15 min

Yes

Glycan[107]

Free biotinylated glycans, glycans tethered to streptavidin

Explored glycan‐lectin pairs: fucose to PA‐IIL lectins and N ‐acetylglucosamine to GafD lectins

In HG

Rational approach:

Chitosan‐SWCNTs noncovalently modified with lectins using a Ni2+‐NTA/His‐tagged protein mechanism for divalent ion based proximity quenching

FI increase

LOD 2 μg/100 ng of glycosylated protein/free glycan to 20 μg of lectin

Greater response of known high affinity pairs than to cross reactions

CoMoCAT

(6,5)

Single sensor

Within

seconds

Yes

Glycoforms with high mannose content[209]

In PBS, metabolically induced hypermannosylation of human IgG from CHO cells, SWCNTs in HG

Rational approach:

Chitosan‐SWCNTs noncovalently modified with PSA‐lectin using a Ni2+‐NTA/His‐tagged protein conjugation for divalent ion based proximity quenching

FI increase

Dissociation constant 1.3–55 μm

Over human/mouse IgG with absent mannose content

HiPCO

ND

Within 5 min

ND

Saccharide[210]

In PBS

Semirational approach:

Phenylboronic acid (PBA) grafted, polyethylene glycol 8‐membered branched polymers (PPEG8) wrapped SWCNTs

Three PBAs to measure saccharide binding:

4‐carboxyphenylboronic acid, N‐(4‐phenylboronic)‐ succinamic acid, 3‐carboxy‐5‐nitrophenylboronic acid

FI quenching

FI changes varied for different saccharide, e.g. 4‐carboxyphenylboronic acid‐PPEG8‐SWCNTs respond with −20 % FI change upon 10 mm ribose and 15 % upon arabinose

Not selective over DA

Most responsive to pentoses, such as arabinose, ribose, and xylose

Chirality mix

(9,4)

ND

1 h incubation of

analytes

ND

Saccharide[211]

In DMSO/PBS

Screening approach:

Polymer or surfactant SWCNTs modified with noncovalent adsorption of PBAs

Saccharide responses occur only within corona phases that have allowed PBAs to adsorb and prequench SWCNT emission (e.g. most PBAs fail to penetrate SDBS corona)

Recognition upon saccharide adsorption into SWCNT corona, followed by surface reaction of PBA

mm range tested

Corona‐phase environment has a profound effect on selectivity of saccharide binding

Chirality mix

ND

Within minutes

ND

[a] FI: fluorescence intensity, ND: ‐not determined, HG: hydrogel, **: limited by the Abbe limit, diffusion and detection speed.

Table 7.

Detailed overview of fluorescent SWCNT based sensors for DNA/RNA.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial resolution

Temporal resolution

Reversibility

DNA hybridization[212]

In Tris buffer

Rational approach:

ssDNA‐SWCNTs

Hybridization of 24‐mer oligonucleotide sequence with its complement causes blue‐shift

LOD 6 nm

Over noncomplementary DNA

HiPCO

(6,5)

ND

13 h to reach steady state (for 625 nm DNA)

ND

MicroRNA/DNA hybridization[163]

In urine, serum, implanted in live mice by using a semipermeable membrane capillary

Rational approach:

SWCNTs functionalized with 23‐mer microRNA capture sequence (complementary to target oligonucleotide) and (GT)15 (for SWCNT colloidal stability)

Low concentrations of SDBS (5.7 mm) cause an increased blue‐shift (and FI enhancement) by an order of magnitude

In buffer: 10 pm–1 μm

In urine: LOD 1 nm

In serum: similar, but addition of proteinase K necessary for detection of RNA (to deactivate RNase, which can degrade RNA sequence)

In vivo: LOD 100 pm

Over random 23‐mer sequences and similar sequences

Chirality mix

Single sensor

Within 10 min/120 min in buffer/in vivo

Kinetics are 1.8 × faster for DNA vs. RNA

Yes, by toe‐hold‐mediated strand displacement, but slower than detection in forward direction

Single nucleotide polymorphism (SNP)[213]

In Tris buffer

Rational approach:

TAG CTA TGG AAT TCC TCG TAG GCA ‐SWCNTs

Blue‐shift upon SNP detection

Not all ssDNA sequences can be used for SNP detection, surface coverage of SWCNTs with ssDNA shouldn't be too high

0.8 meV blue‐shift

Distinction from response caused by complementary DNA due to higher energy shift of 1.2 meV

HiPCO

(6,5)

ND

8 h to reach steady state

ND

ssRNA genome of intact HIV[164]

In PBS, FBS

Rational approach:

(GT)15(T)15‐SWCNTs

SDS for blocking nonspecific binding in serum and denaturation of virus

RNA genome hybridizes to sensor, freeing space on the SWCNT surface, denatured viral proteins bind to the surface, eliciting an enhanced blue‐shift

3–9  nm blue‐shift depending on chirality

Control DNA causes slight red‐shift

HiPCO

(8,6)

ND

Wavelength shift within 20 min

(after 180 min 3  nm shift)

ND

[a] FI: fluorescence intensity, ND: not determined.

Table 8.

Detailed overview of fluorescent SWCNT based sensors for enzymes.[a]

Target

Biological system

Recognition strategy

Sensitivity

Selectivity

SWCNT chirality/ wavelength

Spatial resolution

Temporal resolution

Reversibility

Enzyme activity[166]

In solution

BSA‐SWCNTs for bacterial protease, citrus pectin‐SWCNTs for pectinase, carboxymethylcellulose (CMC)‐SWCNTs for cellulase

Target enzyme degrades the polymer‐wrapping, resulting in FI quenching

LOD 5 fm

Sensitivity and repeatability of sensors varies due to affinity of polymers to the SWCNT

ND

CoMoCAT, (6,5) at 975 nm

ND

Real time

Signal stabilized 1–3 h after incubation (24–29 h for 5 fm)

No

Enzyme activity[167]

In soil, diluted with DI water

Albumin‐SWCNTs for proteolytic activity, lignosulfonic acid (LSA)‐SWCNTs for lignin‐modifying activity, CMC‐SWCNTs for cellulolytic activity

Target enzyme degrades the polymer‐wrapping resulting in FI quenching or target enzyme further protects the SWCNT resulting in FI increase

ND

LSA‐SWCNTs respond to pH changes

CMC‐SWCNTs to nonspecific binding of proteins

Chirality mix, (6,5)

ND

ND

Myeloperoxidase (MPO)[169]

MPO/H2O2/Cl system

GO‐SC‐SWCNTs

Increasing FI at 420/430 nm due to oxidation and degradation of GO

Decreasing NIR SWCNT FI due to generation of defects on the SWCNT surface

Linear response to MPO‐catalyzed degradation

ND

CoMoCAT, 998 nm

GO: 420 nm

ND

Real time, within 5 days

No

Trypsin[168]

SWCNTs drop‐casted and dried on glass fiber paper, fixed on plastic strips

Urine samples diluted in PBS

Screening approach:

Peptide‐SWCNTs (HexCoil‐Ala)

Target enzyme degrades the peptide‐wrapping resulting in FI quenching

1–20 μg mL−1

Urine samples: reduced sensitivity

8.3 %/33 % urine (without trypsin) caused 33 %/50 % FI decrease

over urea

CoMoCAT, (6,5)

ND

Significant FI decrease after 2 h/1 h of incubation at concentrations of 1/5–20 μg mL−1

No

[a] FI: fluorescence intensity, ND: not determined.

Conflict of interest

The authors declare no conflict of interest.

Biographical Information

Julia Ackermann received her M.Sc. in nanoengineering with a focus on nano(opto)electronics at the university of Duisburg‐Essen (Germany). Since 2020 she has been persuing her Ph.D. in the technology division of biomedical nanosensors of the Fraunhofer Institute for Microelectronic Circuits and Systems in Duisburg (Germany). Her work focuses on improving the overall selectivity of carbon nanotube based sensors by pattern recognition.

graphic file with name ANIE-61-0-g023.jpg

Biographical Information

Justus Metternich received his Bachelor's degree in biotechnology from the University of Applied Sciences Darmstadt. After a short stay at the Centro de Investigaciones Biológicas Margarita Salas in 2018, he continued with his Master's studies in chemistry at Uppsala University. Since November 2020, he has been part of the Attract group of Sebastian Kruss and pursuing his Ph.D. at Ruhr‐University Bochum. His research focuses on the design of fluorescent carbon nanotube functionalizations for the detection of pathogens.

graphic file with name ANIE-61-0-g005.jpg

Biographical Information

Svenja Herbertz received her Ph.D. in Physics at the Solid‐State Physics Laboratory at the Heinrich‐Heine‐University in Düsseldorf (Germany) in 2019. During her years of study in Medical Physics she gained experience in the field of optical spectroscopy and use of semiconductor quantum dots for fluorescence labeling in biomedical applications. She is currently a researcher at the Fraunhofer Institute for Microelectronic Circuits and Systems in Duisburg (Germany) in the technology division of biomedical nanosensors.

graphic file with name ANIE-61-0-g004.jpg

Biographical Information

Sebastian Kruss received his Ph.D. in biophysical chemistry at Heidelberg University and the Max Planck Institute for Intelligent Systems (with Prof. Joachim Spatz). He then moved to the Massachusetts Institute of Technology (with Prof. Michael Strano), where he worked on carbon nanomaterials. After heading an independent research group at Göttingen University (2015–2020), he became professor of physical chemistry at Ruhr‐Universität Bochum and Attract group leader at Fraunhofer IMS. His research focuses on novel materials, fluorescence spectroscopy and microscopy, biosensors, and cell biophysics.

graphic file with name ANIE-61-0-g016.jpg

Acknowledgements

This work is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy—EXC 2033–390677874—RESOLV. This work is further supported by the “Center for Solvation Science ZEMOS” funded by the German Federal Ministry of Education and Research BMBF, and by the Ministry of Culture and Research of Nord Rhine‐Westphalia, as well as by the Fraunhofer Internal Programs under Grant No. Attract 038–610097. Open Access funding enabled and organized by Projekt DEAL.

J. Ackermann, J. T. Metternich, S. Herbertz, S. Kruss, Angew. Chem. Int. Ed. 2022, 61, e202112372; Angew. Chem. 2022, 134, e202112372.

References

  • 1. Hong G., Antaris A. L., Dai H., Nat. Biomed. Eng. 2017, 1, 0010. [Google Scholar]
  • 2. Hong G., Diao S., Antaris A. L., Dai H., Chem. Rev. 2015, 115, 10816. [DOI] [PubMed] [Google Scholar]
  • 3. Giraldo J. P., Wu H., Newkirk G. M., Kruss S., Nat. Nanotechnol. 2019, 14, 541. [DOI] [PubMed] [Google Scholar]
  • 4. Swager T. M., Angew. Chem. Int. Ed. 2018, 57, 4248; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 4325. [Google Scholar]
  • 5. 
  • 5a. Howes P. D., Chandrawati R., Stevens M. M., Science 2014, 346, 1247390; [DOI] [PubMed] [Google Scholar]
  • 5b. Howes P. D., Rana S., Stevens M. M., Chem. Soc. Rev. 2014, 43, 3835; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5c. Spicer C. D., Jumeaux C., Gupta B., Stevens M. M., Chem. Soc. Rev. 2018, 47, 3574; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5d. Cheng C., Li S., Thomas A., Kotov N. A., Haag R., Chem. Rev. 2017, 117, 1826. [DOI] [PubMed] [Google Scholar]
  • 6. 
  • 6a. Schroeder V., Savagatrup S., He M., Lin S., Swager T. M., Chem. Rev. 2019, 119, 599; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6b. Tasis D., Tagmatarchis N., Bianco A., Prato M., Chem. Rev. 2006, 106, 1105; [DOI] [PubMed] [Google Scholar]
  • 6c. Reina G., González-Domínguez J. M., Criado A., Vázquez E., Bianco A., Prato M., Chem. Soc. Rev. 2017, 46, 4400; [DOI] [PubMed] [Google Scholar]
  • 6d. Ali-Boucetta H., Kostarelos K., Adv. Drug Delivery Rev. 2013, 65, 1897. [DOI] [PubMed] [Google Scholar]
  • 7. Iijima S., Nature 1991, 354, 56. [Google Scholar]
  • 8. Baughman R. H., Zakhidov A. A., de Heer W. A., Science 2002, 297, 787. [DOI] [PubMed] [Google Scholar]
  • 9. Boghossian A. A., Zhang J., Barone P. W., Reuel N. F., Kim J.-H., Heller D. A., Ahn J.-H., Hilmer A. J., Rwei A., Arkalgud J. R., et al., ChemSusChem 2011, 4, 848. [DOI] [PubMed] [Google Scholar]
  • 10. Kruss S., Hilmer A. J., Zhang J., Reuel N. F., Mu B., Strano M. S., Adv. Drug Delivery Rev. 2013, 65, 1933. [DOI] [PubMed] [Google Scholar]
  • 11. Barone P. W., Strano M. S., Angew. Chem. Int. Ed. 2006, 45, 8138; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2006, 118, 8318. [Google Scholar]
  • 12. Bachilo S. M., Strano M. S., Kittrell C., Hauge R. H., Smalley R. E., Weisman R. B., Science 2002, 298, 2361. [DOI] [PubMed] [Google Scholar]
  • 13. Zhang J., Boghossian A. A., Barone P. W., Rwei A., Kim J.-H., Lin D., Heller D. A., Hilmer A. J., Nair N., Reuel N. F., et al., J. Am. Chem. Soc. 2011, 133, 567. [DOI] [PubMed] [Google Scholar]
  • 14. Pan J., Li F., Choi J. H., J. Mater. Chem. B 2017, 5, 6511. [DOI] [PubMed] [Google Scholar]
  • 15. Kruss S., Landry M. P., Vander Ende E., Lima B. M. A., Reuel N. F., Zhang J., Nelson J., Mu B., Hilmer A., Strano M., J. Am. Chem. Soc. 2014, 136, 713. [DOI] [PubMed] [Google Scholar]
  • 16. Farrera C., Torres Andón F., Feliu N., ACS Nano 2017, 11, 10637. [DOI] [PubMed] [Google Scholar]
  • 17. Coleman J. N., Adv. Funct. Mater. 2009, 19, 3680. [Google Scholar]
  • 18. O′Connell M. J., Bachilo S. M., Huffman C. B., Moore V. C., Strano M. S., Haroz E. H., Rialon K. L., Boul P. J., Noon W. H., Kittrell C., et al., Science 2002, 297, 593. [DOI] [PubMed] [Google Scholar]
  • 19. Giraldo J. P., Landry M. P., Faltermeier S. M., McNicholas T. P., Iverson N. M., Boghossian A. A., Reuel N. F., Hilmer A. J., Sen F., Brew J. A., et al., Nat. Mater. 2014, 13, 400. [DOI] [PubMed] [Google Scholar]
  • 20. Giraldo J. P., Landry M. P., Kwak S.-Y., Jain R. M., Wong M. H., Iverson N. M., Ben-Naim M., Strano M. S., Small 2015, 11, 3973. [DOI] [PubMed] [Google Scholar]
  • 21. Yi H., Ghosh D., Ham M.-H., Qi J., Barone P. W., Strano M. S., Belcher A. M., Nano Lett. 2012, 12, 1176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Zheng M., Jagota A., Semke E. D., Diner B. A., McLean R. S., Lustig S. R., Richardson R. E., Tassi N. G., Nat. Mater. 2003, 2, 338. [DOI] [PubMed] [Google Scholar]
  • 23. Oliveira S. F., Bisker G., Bakh N. A., Gibbs S. L., Landry M. P., Strano M. S., Carbon 2015, 95, 767. [Google Scholar]
  • 24. Barone P. W., Baik S., Heller D. A., Strano M. S., Nat. Mater. 2004, 4, 86. [DOI] [PubMed] [Google Scholar]
  • 25. Heller D. A., Jeng E. S., Yeung T.-K., Martinez B. M., Moll A. E., Gastala J. B., Strano M. S., Science 2006, 311, 508. [DOI] [PubMed] [Google Scholar]
  • 26. Gillen A. J., Boghossian A. A., Front. Chem. 2019, 7, 612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Dinarvand M., Neubert E., Meyer D., Selvaggio G., Mann F. A., Erpenbeck L., Kruss S., Nano Lett. 2019, 19, 6604. [DOI] [PubMed] [Google Scholar]
  • 28. Dinarvand M., Elizarova S., Daniel J., Kruss S., ChemPlusChem 2020, 85, 1465. [DOI] [PubMed] [Google Scholar]
  • 29. Nißler R., Bader O., Dohmen M., Walter S. G., Noll C., Selvaggio G., Groß U., Kruss S., Nat. Commun. 2020, 11, 5995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Wong M. H., Giraldo J. P., Kwak S.-Y., Koman V. B., Sinclair R., Lew T. T. S., Bisker G., Liu P., Strano M. S., Nat. Mater. 2017, 16, 264. [DOI] [PubMed] [Google Scholar]
  • 31. Wu H., Nißler R., Morris V., Herrmann N., Hu P., Jeon S.-J., Kruss S., Giraldo J. P., Nano Lett. 2020, 20, 2432. [DOI] [PubMed] [Google Scholar]
  • 32. Lew T. T. S., Koman V. B., Silmore K. S., Seo J. S., Gordiichuk P., Kwak S.-Y., Park M., Ang M. C.-Y., Khong D. T., Lee M. A., et al., Nat. Plants 2020, 6, 404. [DOI] [PubMed] [Google Scholar]
  • 33. Lew T. T. S., Park M., Cui J., Strano M. S., Adv. Mater. 2021, 33, 2005683. [DOI] [PubMed] [Google Scholar]
  • 34. Landry M. P., Kruss S., Nelson J. T., Bisker G., Iverson N. M., Reuel N. F., Strano M. S., Sensors 2014, 14, 16196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Hendler-Neumark A., Bisker G., Sensors 2019, 19, 5403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. de Volder M. F. L., Tawfick S. H., Baughman R. H., Hart A. J., Science 2013, 339, 535. [DOI] [PubMed] [Google Scholar]
  • 37. Dresselhaus M. S., Dresselhaus G., Charlier J. C., Hernández E., Philos. Trans. A 2004, 362, 2065. [DOI] [PubMed] [Google Scholar]
  • 38. Iijima S., Ichihashi T., Nature 1993, 363, 603. [Google Scholar]
  • 39. Dresselhaus M. S., Dresselhaus G., Saito R., Carbon 1995, 33, 883. [Google Scholar]
  • 40. Ma J., Wang J. N., Wang X. X., J. Mater. Chem. 2009, 19, 3033. [Google Scholar]
  • 41. Wang F., Dukovic G., Brus L. E., Heinz T. F., Science 2005, 308, 838. [DOI] [PubMed] [Google Scholar]
  • 42. Manzoni C., Gambetta A., Menna E., Meneghetti M., Lanzani G., Cerullo G., Phys. Rev. Lett. 2005, 94, 207401. [DOI] [PubMed] [Google Scholar]
  • 43. Zhao H., Mazumdar S., Phys. Rev. Lett. 2004, 93, 157402. [DOI] [PubMed] [Google Scholar]
  • 44. Ando T., J. Phys. Soc. Jpn. 2006, 75, 024707. [Google Scholar]
  • 45. 
  • 45a. Spataru C. D., Ismail-Beigi S., Capaz R. B., Louie S. G., Phys. Rev. Lett. 2005, 95, 247402; [DOI] [PubMed] [Google Scholar]
  • 45b. Berciaud S., Cognet L., Lounis B., Phys. Rev. Lett. 2008, 101, 77402; [DOI] [PubMed] [Google Scholar]
  • 45c. Srivastava A., Htoon H., Klimov V. I., Kono J., Phys. Rev. Lett. 2008, 101, 87402. [DOI] [PubMed] [Google Scholar]
  • 46. Lüer L., Hoseinkhani S., Polli D., Crochet J., Hertel T., Lanzani G., Nat. Phys. 2009, 5, 54. [Google Scholar]
  • 47. Cognet L., Tsyboulski D. A., Rocha J.-D. R., Doyle C. D., Tour J. M., Weisman R. B., Science 2007, 316, 1465. [DOI] [PubMed] [Google Scholar]
  • 48. Siitonen A. J., Tsyboulski D. A., Bachilo S. M., Weisman R. B., Nano Lett. 2010, 10, 1595. [DOI] [PubMed] [Google Scholar]
  • 49. Nißler R., Kurth L., Li H., Spreinat A., Kuhlemann I., Flavel B. S., Kruss S., Anal. Chem. 2021, 93, 6446. [DOI] [PubMed] [Google Scholar]
  • 50. 
  • 50a. Kou L., Labrie D., Chylek P., Appl. Opt. 1993, 32, 3531; [DOI] [PubMed] [Google Scholar]
  • 50b.Scott Prahl, “Tabulated Molar Extinction Coefficient for Hemoglobin in Water”, can be found under https://omlc.org/spectra/hemoglobin/summary.html, 2018.
  • 51. Karousis N., Tagmatarchis N., Tasis D., Chem. Rev. 2010, 110, 5366. [DOI] [PubMed] [Google Scholar]
  • 52. 
  • 52a. Singh P., Campidelli S., Giordani S., Bonifazi D., Bianco A., Prato M., Chem. Soc. Rev. 2009, 38, 2214; [DOI] [PubMed] [Google Scholar]
  • 52b. Hirsch A., Angew. Chem. Int. Ed. 2002, 41, 1853; [Google Scholar]; Angew. Chem. 2002, 114, 1933; [Google Scholar]
  • 52c. Bilalis P., Katsigiannopoulos D., Avgeropoulos A., Sakellariou G., RSC Adv. 2014, 4, 2911; [Google Scholar]
  • 52d. Dyke C. A., Tour J. M., J. Phys. Chem. A 2004, 108, 11151; [Google Scholar]
  • 52e. Wu H.-C., Chang X., Liu L., Zhao F., Zhao Y., J. Mater. Chem. 2010, 20, 1036; [Google Scholar]
  • 52f. Liu Z., Tabakman S. M., Chen Z., Dai H., Nat. Protoc. 2009, 4, 1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Brozena A. H., Kim M., Powell L. R., Wang Y., Nat. Rev. Chem. 2019, 3, 375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. 
  • 54a. Ernst F., Heek T., Setaro A., Haag R., Reich S., Adv. Funct. Mater. 2012, 22, 3921; [Google Scholar]
  • 54b. Ernst F., Heek T., Setaro A., Haag R., Reich S., J. Phys. Chem. C 2013, 117, 1157. [Google Scholar]
  • 55. Tu X., Manohar S., Jagota A., Zheng M., Nature 2009, 460, 250. [DOI] [PubMed] [Google Scholar]
  • 56. Salem D. P., Gong X., Liu A. T., Koman V. B., Dong J., Strano M. S., J. Am. Chem. Soc. 2017, 139, 16791. [DOI] [PubMed] [Google Scholar]
  • 57. Gillen A. J., Kupis-Rozmysłowicz J., Gigli C., Schuergers N., Boghossian A. A., J. Phys. Chem. Lett. 2018, 9, 4336. [DOI] [PubMed] [Google Scholar]
  • 58. 
  • 58a. Tomonari Y., Murakami H., Nakashima N., Chemistry 2006, 12, 4027; [DOI] [PubMed] [Google Scholar]
  • 58b. Zhao Y.-L., Hu L., Stoddart J. F., Grüner G., Adv. Mater. 2008, 20, 1910; [Google Scholar]
  • 58c. Petrov P., Stassin F., Pagnoulle C., Jérôme R., Chem. Commun. 2003, 2904. [DOI] [PubMed] [Google Scholar]
  • 59. 
  • 59a. Wang S., Humphreys E. S., Chung S.-Y., Delduco D. F., Lustig S. R., Wang H., Parker K. N., Rizzo N. W., Subramoney S., Chiang Y.-M., et al., Nat. Mater. 2003, 2, 196; [DOI] [PubMed] [Google Scholar]
  • 59b. Zorbas V., Ortiz-Acevedo A., Dalton A. B., Yoshida M. M., Dieckmann G. R., Draper R. K., Baughman R. H., Jose-Yacaman M., Musselman I. H., J. Am. Chem. Soc. 2004, 126, 7222; [DOI] [PubMed] [Google Scholar]
  • 59c. Dieckmann G. R., Dalton A. B., Johnson P. A., Razal J., Chen J., Giordano G. M., Muñoz E., Musselman I. H., Baughman R. H., Draper R. K., J. Am. Chem. Soc. 2003, 125, 1770; [DOI] [PubMed] [Google Scholar]
  • 59d. Mann F. A., Horlebein J., Meyer N. F., Meyer D., Thomas F., Kruss S., Chemistry 2018, 24, 12241. [DOI] [PubMed] [Google Scholar]
  • 60. Antonucci A., Kupis-Rozmysłowicz J., Boghossian A. A., ACS Appl. Mater. Interfaces 2017, 9, 11321. [DOI] [PubMed] [Google Scholar]
  • 61. Karajanagi S. S., Yang H., Asuri P., Sellitto E., Dordick J. S., Kane R. S., Langmuir 2006, 22, 1392. [DOI] [PubMed] [Google Scholar]
  • 62. Fujigaya T., Nakashima N., Sci. Technol. Adv. Mater. 2015, 16, 024802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Polo E., Kruss S., J. Phys. Chem. C 2016, 120, 3061. [Google Scholar]
  • 64. Zhang J., Kruss S., Hilmer A. J., Shimizu S., Schmois Z., de La Cruz F., Barone P. W., Reuel N. F., Heller D. A., Strano M. S., Adv. Healthcare Mater. 2014, 3, 412. [DOI] [PubMed] [Google Scholar]
  • 65. Williams R. M., Lee C., Galassi T. V., Harvey J. D., Leicher R., Sirenko M., Dorso M. A., Shah J., Olvera N., Dao F., et al., Sci. Adv. 2018, 4, eaaq1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Polo E., Nitka T. T., Neubert E., Erpenbeck L., Vuković L., Kruss S., ACS Appl. Mater. Interfaces 2018, 10, 17693. [DOI] [PubMed] [Google Scholar]
  • 67. Mann F. A., Lv Z., Großhans J., Opazo F., Kruss S., Angew. Chem. Int. Ed. 2019, 58, 11469; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2019, 131, 11591. [Google Scholar]
  • 68. Yum K., Ahn J.-H., McNicholas T. P., Barone P. W., Mu B., Kim J.-H., Jain R. M., Strano M. S., ACS Nano 2012, 6, 819. [DOI] [PubMed] [Google Scholar]
  • 69. Tsai T.-W., Heckert G., Neves L. F., Tan Y., Kao D.-Y., Harrison R. G., Resasco D. E., Schmidtke D. W., Anal. Chem. 2009, 81, 7917. [DOI] [PubMed] [Google Scholar]
  • 70. Zhang J., Landry M. P., Barone P. W., Kim J.-H., Lin S., Ulissi Z. W., Lin D., Mu B., Boghossian A. A., Hilmer A. J., et al., Nat. Nanotechnol. 2013, 8, 959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Bisker G., Dong J., Park H. D., Iverson N. M., Ahn J., Nelson J. T., Landry M. P., Kruss S., Strano M. S., Nat. Commun. 2016, 7, 10241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Setaro A., Adeli M., Glaeske M., Przyrembel D., Bisswanger T., Gordeev G., Maschietto F., Faghani A., Paulus B., Weinelt M., et al., Nat. Commun. 2017, 8, 14281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. 
  • 73a. He X., Htoon H., Doorn S. K., Pernice W. H. P., Pyatkov F., Krupke R., Jeantet A., Chassagneux Y., Voisin C., Nat. Mater. 2018, 17, 663; [DOI] [PubMed] [Google Scholar]
  • 73b. Miyauchi Y., Iwamura M., Mouri S., Kawazoe T., Ohtsu M., Matsuda K., Nat. Photonics 2013, 7, 715. [Google Scholar]
  • 74. Piao Y., Meany B., Powell L. R., Valley N., Kwon H., Schatz G. C., Wang Y., Nat. Chem. 2013, 5, 840. [DOI] [PubMed] [Google Scholar]
  • 75. Ghosh S., Bachilo S. M., Simonette R. A., Beckingham K. M., Weisman R. B., Science 2010, 330, 1656. [DOI] [PubMed] [Google Scholar]
  • 76. Wang Q. H., Strano M. S., Nat. Chem. 2013, 5, 812. [DOI] [PubMed] [Google Scholar]
  • 77. Lin C.-W., Bachilo S. M., Zheng Y., Tsedev U., Huang S., Weisman R. B., Belcher A. M., Nat. Commun. 2019, 10, 2874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Chiu C. F., Saidi W. A., Kagan V. E., Star A., J. Am. Chem. Soc. 2017, 139, 4859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Mann F. A., Herrmann N., Opazo F., Kruss S., Angew. Chem. Int. Ed. 2020, 59, 17732; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2020, 132, 17885. [Google Scholar]
  • 80. Chio L., Pinals R. L., Murali A., Goh N. S., Landry M. P., Adv. Funct. Mater. 2020, 30, 1910556. [Google Scholar]
  • 81. Shiraki T., Onitsuka H., Shiraishi T., Nakashima N., Chem. Commun. 2016, 52, 12972. [DOI] [PubMed] [Google Scholar]
  • 82. 
  • 82a. Janas D., Mater. Horiz. 2020, 7, 2860; [Google Scholar]
  • 82b. Shiraki T., Chem. Lett. 2021, 50, 397. [Google Scholar]
  • 83. Shiraki T., Uchimura S., Shiraishi T., Onitsuka H., Nakashima N., Chem. Commun. 2017, 53, 12544. [DOI] [PubMed] [Google Scholar]
  • 84. Hansch C., Leo A., Taft R. W., Chem. Rev. 1991, 91, 165. [Google Scholar]
  • 85. Kwon H., Kim M., Meany B., Piao Y., Powell L. R., Wang Y., J. Phys. Chem. C 2015, 119, 3733. [Google Scholar]
  • 86. 
  • 86a. Freeley M., Worthy H. L., Ahmed R., Bowen B., Watkins D., Macdonald J. E., Zheng M., Jones D. D., Palma M., J. Am. Chem. Soc. 2017, 139, 17834; [DOI] [PubMed] [Google Scholar]
  • 86b. Clément P., Trinchera P., Cervantes-Salguero K., Ye Q., Jones C. R., Palma M., ChemPlusChem 2019, 84, 1235; [DOI] [PubMed] [Google Scholar]
  • 86c. Amoroso G., Ye Q., Cervantes-Salguero K., Fernández G., Cecconello A., Palma M., Chem. Mater. 2019, 31, 1537. [Google Scholar]
  • 87. Spreinat A., Dohmen M. M., Lüttgens J., Herrmann N., Klepzig L. F., Nißler R., Weber S., Mann F. A., Lauth J., Kruss S., J. Phys. Chem. C 2021, 125, 18341. [Google Scholar]
  • 88. Heller D. A., Jena P. V., Pasquali M., Kostarelos K., Delogu L. G., Meidl R. E., Rotkin S. V., Scheinberg D. A., Schwartz R. E., Terrones M., et al., Nat. Nanotechnol. 2020, 15, 164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Aoki K., Saito N., Nanomaterials 2020, 10, 264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Kagan V. E., Konduru N. V., Feng W., Allen B. L., Conroy J., Volkov Y., Vlasova I. I., Belikova N. A., Yanamala N., Kapralov A., et al., Nat. Nanotechnol. 2010, 5, 354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Elgrabli D., Dachraoui W., Ménard-Moyon C., Liu X. J., Bégin D., Bégin-Colin S., Bianco A., Gazeau F., Alloyeau D., ACS Nano 2015, 9, 10113. [DOI] [PubMed] [Google Scholar]
  • 92. Monopoli M. P., Aberg C., Salvati A., Dawson K. A., Nat. Nanotechnol. 2012, 7, 779. [DOI] [PubMed] [Google Scholar]
  • 93. Gravely M., Safaee M. M., Roxbury D., Nano Lett. 2019, 19, 6203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Gravely M., Roxbury D., ACS Nano 2021, 15, 12388. [DOI] [PubMed] [Google Scholar]
  • 95. Ali-Boucetta H., Nunes A., Sainz R., Herrero M. A., Tian B., Prato M., Bianco A., Kostarelos K., Angew. Chem. Int. Ed. 2013, 52, 2274; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2013, 125, 2330. [Google Scholar]
  • 96. Galassi T. V., Antman-Passig M., Yaari Z., Jessurun J., Schwartz R. E., Heller D. A., PLoS One 2020, 15, e0226791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Fadeel B., Kostarelos K., Nat. Nanotechnol. 2020, 15, 164. [DOI] [PubMed] [Google Scholar]
  • 98. Pinals R. L., Yang D., Rosenberg D. J., Chaudhary T., Crothers A. R., Iavarone A. T., Hammel M., Landry M. P., Angew. Chem. Int. Ed. 2020, 59, 23668; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2020, 132, 23876. [Google Scholar]
  • 99. Faria M., Björnmalm M., Thurecht K. J., Kent S. J., Parton R. G., Kavallaris M., Johnston A. P. R., Gooding J. J., Corrie S. R., Boyd B. J., et al., Nat. Nanotechnol. 2018, 13, 777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Kruss S., Salem D. P., Vuković L., Lima B., Vander Ende E., Boyden E. S., Strano M. S., Proc. Natl. Acad. Sci. USA 2017, 114, 1789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Bisker G., Bakh N. A., Lee M. A., Ahn J., Park M., O'Connell E. B., Iverson N. M., Strano M. S., ACS Sens. 2018, 3, 367. [DOI] [PubMed] [Google Scholar]
  • 102. Satishkumar B. C., Brown L. O., Gao Y., Wang C.-C., Wang H.-L., Doorn S. K., Nat. Nanotechnol. 2007, 2, 560. [DOI] [PubMed] [Google Scholar]
  • 103. Ahn J.-H., Kim J.-H., Reuel N. F., Barone P. W., Boghossian A. A., Zhang J., Yoon H., Chang A. C., Hilmer A. J., Strano M. S., Nano Lett. 2011, 11, 2743. [DOI] [PubMed] [Google Scholar]
  • 104. Nelson J. T., Kim S., Reuel N. F., Salem D. P., Bisker G., Landry M. P., Kruss S., Barone P. W., Kwak S., Strano M. S., Anal. Chem. 2015, 87, 8186. [DOI] [PubMed] [Google Scholar]
  • 105. Landry M. P., Ando H., Chen A. Y., Cao J., Kottadiel V. I., Chio L., Yang D., Dong J., Lu T. K., Strano M. S., Nat. Nanotechnol. 2017, 12, 368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Williams R. M., Lee C., Heller D. A., ACS Sens. 2018, 3, 1838. [DOI] [PubMed] [Google Scholar]
  • 107. Reuel N. F., Ahn J.-H., Kim J.-H., Zhang J., Boghossian A. A., Mahal L. K., Strano M. S., J. Am. Chem. Soc. 2011, 133, 17923. [DOI] [PubMed] [Google Scholar]
  • 108. Yoon H., Ahn J.-H., Barone P. W., Yum K., Sharma R., Boghossian A. A., Han J.-H., Strano M. S., Angew. Chem. Int. Ed. 2011, 50, 1828; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2011, 123, 1868. [Google Scholar]
  • 109. Jin H., Jeng E. S., Heller D. A., Jena P. V., Kirmse R., Langowski J., Strano M. S., Macromolecules 2007, 40, 6731. [Google Scholar]
  • 110. Heller D. A., Jin H., Martinez B. M., Patel D., Miller B. M., Yeung T.-K., Jena P. V., Höbartner C., Ha T., Silverman S. K., et al., Nat. Nanotechnol. 2009, 4, 114. [DOI] [PubMed] [Google Scholar]
  • 111. Bhattacharya S., Gong X., Wang E., Dutta S. K., Caplette J. R., Son M., Nguyen F. T., Strano M. S., Mukhopadhyay D., Cancer Res. 2019, 79, 4515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Safaee M. M., Gravely M., Roxbury D., Adv. Funct. Mater. 2021, 31, 2006254. [Google Scholar]
  • 113. Iverson N. M., Bisker G., Farias E., Ivanov V., Ahn J., Wogan G. N., Strano M. S., J. Biomed. Nanotechnol. 2016, 12, 1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Polo E., Kruss S., Anal. Bioanal. Chem. 2016, 408, 2727. [DOI] [PubMed] [Google Scholar]
  • 115. Harvey J. D., Williams R. M., Tully K. M., Baker H. A., Shamay Y., Heller D. A., Nano Lett. 2019, 19, 4343. [DOI] [PubMed] [Google Scholar]
  • 116. Salem D. P., Gong X., Liu A. T., Akombi K., Strano M. S., Anal. Chem. 2020, 92, 916. [DOI] [PubMed] [Google Scholar]
  • 117. Jena P. V., Roxbury D., Galassi T. V., Akkari L., Horoszko C. P., Iaea D. B., Budhathoki-Uprety J., Pipalia N., Haka A. S., Harvey J. D., et al., ACS Nano 2017, 11, 10689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Mann F. A., Herrmann N., Meyer D., Kruss S., Sensors 2017, 17, 1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119. Beyene A. G., Alizadehmojarad A. A., Dorlhiac G., Goh N., Streets A. M., Král P., Vuković L., Landry M. P., Nano Lett. 2018, 18, 6995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Beyene A. G., Delevich K., Del Bonis-O'Donnell J. T., Piekarski D. J., Lin W. C., Thomas A. W., Yang S. J., Kosillo P., Yang D., Prounis G. S., et al., Sci. Adv. 2019, 5, eaaw3108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121. Nißler R., Mann F. A., Preiß H., Selvaggio G., Herrmann N., Kruss S., Nanoscale 2019, 11, 11159. [DOI] [PubMed] [Google Scholar]
  • 122. Mittler R., Vanderauwera S., Suzuki N., Miller G., Tognetti V. B., Vandepoele K., Gollery M., Shulaev V., Van Breusegem F., Trends Plant Sci. 2011, 16, 300. [DOI] [PubMed] [Google Scholar]
  • 123. Zulfugarov I. S., Tovuu A., Kim J.-H., Lee C.-H., J. Plant Biol. 2011, 54, 351. [Google Scholar]
  • 124. Kim J.-H., Heller D. A., Jin H., Barone P. W., Song C., Zhang J., Trudel L. J., Wogan G. N., Tannenbaum S. R., Strano M. S., Nat. Chem. 2009, 1, 473. [DOI] [PubMed] [Google Scholar]
  • 125. Jin H., Heller D. A., Kalbacova M., Kim J.-H., Zhang J., Boghossian A. A., Maheshri N., Strano M. S., Nat. Nanotechnol. 2010, 5, 302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126. Kim J.-H., Patra C. R., Arkalgud J. R., Boghossian A. A., Zhang J., Han J.-H., Reuel N. F., Ahn J.-H., Mukhopadhyay D., Strano M. S., ACS Nano 2011, 5, 7848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Iverson N. M., Barone P. W., Shandell M., Trudel L. J., Sen S., Sen F., Ivanov V., Atolia E., Farias E., McNicholas T. P., et al., Nat. Nanotechnol. 2013, 8, 873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128. Ulissi Z. W., Sen F., Gong X., Sen S., Iverson N., Boghossian A. A., Godoy L. C., Wogan G. N., Mukhopadhyay D., Strano M. S., Nano Lett. 2014, 14, 4887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129. Meier J., Stapleton J., Hofferber E., Haworth A., Kachman S., Iverson N. M., Nanomaterials 2021, 11, 243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130. Petrov V. D., Van Breusegem F., AoB PLANTS 2012, 2012, pls014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131. Zheng Y., Bachilo S. M., Weisman R. B., J. Phys. Chem. Lett. 2017, 8, 1952. [DOI] [PubMed] [Google Scholar]
  • 132. Zheng Y., Bachilo S. M., Weisman R. B., ACS Nano 2019, 13, 8222. [DOI] [PubMed] [Google Scholar]
  • 133. Niyonambaza S. D., Kumar P., Xing P., Mathault J., de Koninck P., Boisselier E., Boukadoum M., Miled A., Appl. Sci. 2019, 9, 4719. [Google Scholar]
  • 134. Jeong S., Yang D., Beyene A. G., Del Bonis-O'Donnell J. T., Gest A. M. M., Navarro N., Sun X., Landry M. P., Sci. Adv. 2019, 5, eaay3771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135. Elizarova S., Chouaib A., Shaib A., Mann F., Brose N., Kruss S., Daniel J. A., bioRxiv 2021, DOI 10.1101/2021.03.28.437019. [Google Scholar]
  • 136. Gillen A. J., Antonucci A., Reggente M., Morales D., Boghossian A. A., bioRxiv 2021, DOI 10.1101/2021.02.20.428669. [Google Scholar]
  • 137. Gillen A. J., Siefman D. J., Wu S.-J., Bourmaud C., Lambert B., Boghossian A. A., J. Colloid Interface Sci. 2020, 565, 55. [DOI] [PubMed] [Google Scholar]
  • 138. 
  • 138a. Neubert E., Meyer D., Rocca F., Günay G., Kwaczala-Tessmann A., Grandke J., Senger-Sander S., Geisler C., Egner A., Schön M. P., et al., Nat. Commun. 2018, 9, 3767; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138b. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D. S., Weinrauch Y., Zychlinsky A., Science 2004, 303, 1532. [DOI] [PubMed] [Google Scholar]
  • 139. Meyer D., Telele S., Zelená A., Gillen A. J., Antonucci A., Neubert E., Nißler R., Mann F. A., Erpenbeck L., Boghossian A. A., et al., Nanoscale 2020, 12, 9104. [DOI] [PubMed] [Google Scholar]
  • 140. Kim J.-H., Ahn J.-H., Barone P. W., Jin H., Zhang J., Heller D. A., Strano M. S., Angew. Chem. Int. Ed. 2010, 49, 1456; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2010, 122, 1498. [Google Scholar]
  • 141. Heller D. A., Pratt G. W., Zhang J., Nair N., Hansborough A. J., Boghossian A. A., Reuel N. F., Barone P. W., Strano M. S., Proc. Natl. Acad. Sci. USA 2011, 108, 8544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142. Lee M. A., Nguyen F. T., Scott K., Chan N. Y. L., Bakh N. A., Jones K. K., Pham C., Garcia-Salinas P., Garcia-Parraga D., Fahlman A., et al., ACS Sens. 2019, 4, 32. [DOI] [PubMed] [Google Scholar]
  • 143. Del Bonis-O'Donnell J. T., Pinals R. L., Jeong S., Thakrar A., Wolfinger R. D., Landry M. P., Biochemistry 2019, 58, 54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144. Lee M. A., Wang S., Jin X., Bakh N. A., Nguyen F. T., Dong J., Silmore K. S., Gong X., Pham C., Jones K. K., et al., Adv. Healthc. Mater. 2020, 9, 2000429. [DOI] [PubMed] [Google Scholar]
  • 145. Shumeiko V., Malach E., Helman Y., Paltiel Y., Bisker G., Hayouka Z., Shoseyov O., Sens. Actuators B 2021, 327, 128832. [Google Scholar]
  • 146. Shumeiko V., Paltiel Y., Bisker G., Hayouka Z., Shoseyov O., Biosens. Bioelectron. 2021, 172, 112763. [DOI] [PubMed] [Google Scholar]
  • 147. Dong J., Lee M. A., Rajan A. G., Rahaman I., Sun J. H., Park M., Salem D. P., Strano M. S., Proc. Natl. Acad. Sci. USA 2020, 117, 26616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148. Nißler R., Müller A. T., Dohrman F., Kurth L., Li H., Cosio E. G., Flavel B. S., Giraldo J. P., Mithöfer A., Kruss S., Angew. Chem. Int. Ed. 2022, 61, e202108373; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2022, 134, e202108373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149. Galassi T. V., Jena P. V., Shah J., Ao G., Molitor E., Bram Y., Frankel A., Park J., Jessurun J., Ory D. S., et al., Sci. Transl. Med. 2018, 10, eaar2680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150. Rao V. S., Srinivas K., Sujini G. N., Kumar G. N. S., Int. J. Proteomics 2014, 2014, 147648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151. Dong J., Salem D. P., Sun J. H., Strano M. S., ACS Nano 2018, 12, 3769. [DOI] [PubMed] [Google Scholar]
  • 152. Budhathoki-Uprety J., Shah J., Korsen J. A., Wayne A. E., Galassi T. V., Cohen J. R., Harvey J. D., Jena P. V., Ramanathan L. V., Jaimes E. A., et al., Nat. Commun. 2019, 10, 3605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153. Chio L., Del Bonis-O'Donnell J. T., Kline M. A., Kim J. H., McFarlane I. R., Zuckermann R. N., Landry M. P., Nano Lett. 2019, 19, 7563. [DOI] [PubMed] [Google Scholar]
  • 154. Williams R. M., Harvey J. D., Budhathoki-Uprety J., Heller D. A., Nano Lett. 2020, 20, 7287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.T.-G. Cha, B. A. Baker, M. D. Sauffer, J. H. Choi in 2010 18th Biennial University/Government/Industry Micro/Nano Symposium, IEEE, 2010-2010, pp. 1–4.
  • 156. Cha T.-G., Baker B. A., Sauffer M. D., Salgado J., Jaroch D., Rickus J. L., Porterfield D. M., Choi J. H., ACS Nano 2011, 5, 4236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157. Pinals R. L., Ledesma F., Yang D., Navarro N., Jeong S., Pak J. E., Kuo L., Chuang Y.-C., Cheng Y.-W., Sun H.-Y., et al., Nano Lett. 2021, 21, 2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158. Ehrlich R., Hendler-Neumark A., Wulf V., Amir D., Bisker G., Small 2021, 17, 2101660. [DOI] [PubMed] [Google Scholar]
  • 159. Kozawa D., Cho S.-Y., Gong X., Nguyen F. T., Jin X., Lee M. A., Lee H., Zeng A., Xue G., Schacherl J., et al., ACS Nano 2020, 14, 10141. [DOI] [PubMed] [Google Scholar]
  • 160. Yaari Z., Yang Y., Apfelbaum E., Cupo C., Settle A. H., Cullen Q., Cai W., Roche K. L., Levine D. A., Fleisher M., et al., Sci. Adv. 2021, 7, eabj0852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161. Zubkovs V., Schuergers N., Lambert B., Ahunbay E., Boghossian A. A., Small 2017, 13, 1701654. [DOI] [PubMed] [Google Scholar]
  • 162. Karachevtsev V. A., Glamazda A., Leontiev V. S., Lytvyn O. S., Dettlaff-Weglikowska U., Chem. Phys. Lett. 2007, 435, 104. [Google Scholar]
  • 163. Harvey J. D., Jena P. V., Baker H. A., Zerze G. H., Williams R. M., Galassi T. V., Roxbury D., Mittal J., Heller D. A., Nat. Biomed. Eng. 2017, 1, 0041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164. Harvey J. D., Baker H. A., Ortiz M. V., Kentsis A., Heller D. A., ACS Sens. 2019, 4, 1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165. Cha T.-G., Pan J., Chen H., Salgado J., Li X., Mao C., Choi J. H., Nat. Nanotechnol. 2014, 9, 39. [DOI] [PubMed] [Google Scholar]
  • 166. Kallmyer N. E., Musielewicz J., Sutter J., Reuel N. F., Anal. Chem. 2018, 90, 5209. [DOI] [PubMed] [Google Scholar]
  • 167. Kallmyer N. E., Abdennadher M. S., Agarwal S., Baldwin-Kordick R., Khor R. L., Kooistra A. S., Peterson E., McDaniel M. D., Reuel N. F., Anal. Chem. 2021, 93, 4800. [DOI] [PubMed] [Google Scholar]
  • 168. Shumeiko V., Paltiel Y., Bisker G., Hayouka Z., Shoseyov O., Sensors 2020, 20, 5247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169. He X., White D. L., Kapralov A. A., Kagan V. E., Star A., Anal. Chem. 2020, 92, 12880. [DOI] [PubMed] [Google Scholar]
  • 170. Bardhan N. M., Ghosh D., Belcher A. M., Nat. Commun. 2014, 5, 4918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171. Selvaggio G., Chizhik A., Nißler R., Kuhlemann L., Meyer D., Vuong L., Preiß H., Herrmann N., Mann F. A., Lv Z., et al., Nat. Commun. 2020, 11, 1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172. Wang F., Dukovic G., Knoesel E., Brus L. E., Heinz T. F., Phys. Rev. B 2004, 70, 241403(R). [Google Scholar]
  • 173. Choi J. H., Strano M. S., Appl. Phys. Lett. 2007, 90, 223114. [Google Scholar]
  • 174. Silvera-Batista C. A., Wang R. K., Weinberg P., Ziegler K. J., Phys. Chem. Chem. Phys. 2010, 12, 6990. [DOI] [PubMed] [Google Scholar]
  • 175. Bergler F. F., Schöppler F., Brunecker F. K., Hailman M., Hertel T., J. Phys. Chem. C 2013, 117, 13318. [Google Scholar]
  • 176. Nißler R., Mann F. A., Chaturvedi P., Horlebein J., Meyer D., Vuković L., Kruss S., J. Phys. Chem. C 2019, 123, 4837. [Google Scholar]
  • 177. Harvey J. D., Zerze G. H., Tully K. M., Mittal J., Heller D. A., J. Phys. Chem. C 2018, 122, 10592. [Google Scholar]
  • 178. He X., Velizhanin K. A., Bullard G., Bai Y., Olivier J.-H., Hartmann N. F., Gifford B. J., Kilina S., Tretiak S., Htoon H., et al., ACS Nano 2018, 12, 8060. [DOI] [PubMed] [Google Scholar]
  • 179. Schäferling M., Angew. Chem. Int. Ed. 2012, 51, 3532; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2012, 124, 3590. [Google Scholar]
  • 180. Meyer D., Hagemann A., Kruss S., ACS Nano 2017, 11, 4017. [DOI] [PubMed] [Google Scholar]
  • 181. Antaris A. L., Yaghi O. K., Hong G., Diao S., Zhang B., Yang J., Chew L., Dai H., Small 2015, 11, 6325. [DOI] [PubMed] [Google Scholar]
  • 182. Antaris A. L., Robinson J. T., Yaghi O. K., Hong G., Diao S., Luong R., Dai H., ACS Nano 2013, 7, 3644. [DOI] [PubMed] [Google Scholar]
  • 183. 
  • 183a. Yang F., Wang X., Zhang D., Yang J., Luo D., Xu Z., Wei J., Wang J.-Q., Xu Z., Peng F., et al., Nature 2014, 510, 522; [DOI] [PubMed] [Google Scholar]
  • 183b. An H., Kumamoto A., Takezaki H., Ohyama S., Qian Y., Inoue T., Ikuhara Y., Chiashi S., Xiang R., Maruyama S., Nanoscale 2016, 8, 14523. [DOI] [PubMed] [Google Scholar]
  • 184. 
  • 184a. Ghosh S., Bachilo S. M., Weisman R. B., Nat. Nanotechnol. 2010, 5, 443; [DOI] [PubMed] [Google Scholar]
  • 184b. Arnold M. S., Green A. A., Hulvat J. F., Stupp S. I., Hersam M. C., Nat. Nanotechnol. 2006, 1, 60. [DOI] [PubMed] [Google Scholar]
  • 185. 
  • 185a. Liu H., Nishide D., Tanaka T., Kataura H., Nat. Commun. 2011, 2, 309; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185b. Flavel B. S., Kappes M. M., Krupke R., Hennrich F., ACS Nano 2013, 7, 3557; [DOI] [PubMed] [Google Scholar]
  • 185c. Tvrdy K., Jain R. M., Han R., Hilmer A. J., McNicholas T. P., Strano M. S., ACS Nano 2013, 7, 1779. [DOI] [PubMed] [Google Scholar]
  • 186. 
  • 186a. Fagan J. A., Khripin C. Y., Silvera Batista C. A., Simpson J. R., Hároz E. H., Hight Walker A. R., Zheng M., Adv. Mater. 2014, 26, 2800; [DOI] [PubMed] [Google Scholar]
  • 186b. Khripin C. Y., Fagan J. A., Zheng M., J. Am. Chem. Soc. 2013, 135, 6822; [DOI] [PubMed] [Google Scholar]
  • 186c. Li H., Gordeev G., Garrity O., Reich S., Flavel B. S., ACS Nano 2019, 13, 2567. [DOI] [PubMed] [Google Scholar]
  • 187. 
  • 187a. Zheng M., Jagota A., Strano M. S., Santos A. P., Barone P., Chou S. G., Diner B. A., Dresselhaus M. S., McLean R. S., Onoa G. B., et al., Science 2003, 302, 1545; [DOI] [PubMed] [Google Scholar]
  • 187b. Nish A., Hwang J.-Y., Doig J., Nicholas R. J., Nat. Nanotechnol. 2007, 2, 640; [DOI] [PubMed] [Google Scholar]
  • 187c. Ozawa H., Ide N., Fujigaya T., Niidome Y., Nakashima N., Chem. Lett. 2011, 40, 239; [DOI] [PubMed] [Google Scholar]
  • 187d. Graf A., Zakharko Y., Schießl S. P., Backes C., Pfohl M., Flavel B. S., Zaumseil J., Carbon 2016, 105, 593. [Google Scholar]
  • 188. Selvaggio G., Weitzel M., Oleksiievets N., Oswald T. A., Nißler R., Mey I. P., Karius V., Enderlein J., Tsukanov R., Kruss S., Nanoscale Adv. 2021, 3, 4541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189. Danné N., Godin A. G., Gao Z., Varela J. A., Groc L., Lounis B., Cognet L., ACS Photonics 2018, 5, 359. [Google Scholar]
  • 190. Mandal A. K., Wu X., Ferreira J. S., Kim M., Powell L. R., Kwon H., Groc L., Wang Y., Cognet L., Sci. Rep. 2020, 10, 5286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191. Fakhri N., Wessel A. D., Willms C., Pasquali M., Klopfenstein D. R., MacKintosh F. C., Schmidt C. F., Science 2014, 344, 1031. [DOI] [PubMed] [Google Scholar]
  • 192. Godin A. G., Varela J. A., Gao Z., Danné N., Dupuis J. P., Lounis B., Groc L., Cognet L., Nat. Nanotechnol. 2017, 12, 238. [DOI] [PubMed] [Google Scholar]
  • 193. Santos S. M., Yuma B., Berciaud S., Shaver J., Gallart M., Gilliot P., Cognet L., Lounis B., Phys. Rev. Lett. 2011, 107, 187401. [DOI] [PubMed] [Google Scholar]
  • 194. 
  • 194a. Akizuki N., Aota S., Mouri S., Matsuda K., Miyauchi Y., Nat. Commun. 2015, 6, 8920; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194b. Aota S., Akizuki N., Mouri S., Matsuda K., Miyauchi Y., Appl. Phys. Express 2016, 9, 045103. [Google Scholar]
  • 195. Del Bonis-O'Donnell J. T., Page R. H., Beyene A. G., Tindall E. G., McFarlane I. R., Landry M. P., Adv. Funct. Mater. 2017, 27, 1702112. [Google Scholar]
  • 196. Paviolo C., Cognet L., Neurobiol. Dis. 2021, 153, 105328. [DOI] [PubMed] [Google Scholar]
  • 197. Roxbury D., Jena P. V., Williams R. M., Enyedi B., Niethammer P., Marcet S., Verhaegen M., Blais-Ouellette S., Heller D. A., Sci. Rep. 2015, 5, 14167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198. Zubkovs V., Antonucci A., Schuergers N., Lambert B., Latini A., Ceccarelli R., Santinelli A., Rogov A., Ciepielewski D., Boghossian A. A., Sci. Rep. 2018, 8, 13770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 199. Brege J. J., Gallaway C., Barron A. R., J. Phys. Chem. C 2007, 111, 17812. [Google Scholar]
  • 200. Jin H., Heller D. A., Kim J.-H., Strano M. S., Nano Lett. 2008, 8, 4299. [DOI] [PubMed] [Google Scholar]
  • 201. Yaari Z., Cheung J. M., Baker H. A., Frederiksen R. S., Jena P. V., Horoszko C. P., Jiao F., Scheuring S., Luo M., Heller D. A., Nano Lett. 2020, 20, 7819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202. Salem D. P., Landry M. P., Bisker G., Ahn J., Kruss S., Strano M. S., Carbon 2016, 97, 147. [Google Scholar]
  • 203. Yang D., Yang S. J., Del Bonis-O'Donnell J. T., Pinals R. L., Landry M. P., ACS Nano 2020, 14, 13794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 204. Pan J., Zhang H., Cha T.-G., Chen H., Choi J. H., Anal. Chem. 2013, 85, 8391. [DOI] [PubMed] [Google Scholar]
  • 205. Welsher K., Liu Z., Daranciang D., Dai H., Nano Lett. 2008, 8, 586. [DOI] [PubMed] [Google Scholar]
  • 206. Roxbury D., Jena P. V., Shamay Y., Horoszko C. P., Heller D. A., ACS Nano 2016, 10, 499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 207. Yang R., Tang Z., Yan J., Kang H., Kim Y., Zhu Z., Tan W., Anal. Chem. 2008, 80, 7408. [DOI] [PubMed] [Google Scholar]
  • 208.P. W. Barone in AIP Conference Proceedings, AIP, 2005, pp. 193–197.
  • 209. Reuel N. F., Grassbaugh B., Kruss S., Mundy J. Z., Opel C., Ogunniyi A. O., Egodage K., Wahl R., Helk B., Zhang J., et al., ACS Nano 2013, 7, 7472. [DOI] [PubMed] [Google Scholar]
  • 210. Mu B., McNicholas T. P., Zhang J., Hilmer A. J., Jin Z., Reuel N. F., Kim J.-H., Yum K., Strano M. S., J. Am. Chem. Soc. 2012, 134, 17620. [DOI] [PubMed] [Google Scholar]
  • 211. Mu B., Ahn J., McNicholas T. P., Strano M. S., Chemistry 2015, 21, 4523. [DOI] [PubMed] [Google Scholar]
  • 212. Jeng E. S., Moll A. E., Roy A. C., Gastala J. B., Strano M. S., Nano Lett. 2006, 6, 371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 213. Jeng E. S., Nelson J. D., Prather K. L. J., Strano M. S., Small 2010, 6, 40. [DOI] [PubMed] [Google Scholar]

Articles from Angewandte Chemie (International Ed. in English) are provided here courtesy of Wiley

RESOURCES